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Abstract
Parasitic helminths infect over a billion people world-wide and contribute to one million 
deaths annually. Therefore, these parasites represent an enormous burden on human health 
and well-being. Amongst the most prevalent of helminth parasites is the round worm Ascaris. 
The development of protective immunity against helminth infections is characterised by 
eosinophilia, mastocytosis and elevated IgE antibody. These responses are loiown to be 
controlled by CD4^ T helper type-2 (Th2) cells through the cytokines they secrete following 
activation. The features of helminth infections that promote the induction of Th2-type 
immune responses are unknown but it has been suggested that parasite-derived products may 
have some involvement. The experiments presented in this thesis analysed the immune 
response resulting from infection with Ascaris suum in the murine host and the contribution of 
the parasite’s products in this process. It was found that infection with Ascaris resulted in the 
generation of a Th2-type response that was influenced by the host MHC haplotype. 
Furthennore the Th2-type response generated by infection could be modulated following 
exposure to the pseiidocolomic fluid (ABF) but not with the major allergen of Ascaris, ABA- 
1. Immunomodulation by ABF was demonstrated further in its ability to suppress 
development of the Thl-associated delayed-type hypersensitivity reaction to a heterologous 
antigen. Immunomodulation by ABF did not require the presence of ABA-1 and was a stable 
phenomenon resistant to both heat and acid treatments. The future identification and analysis 
of the component of ABF responsible for this activity has important implications for the 
mechanisms by which helminth parasites modulate the immune response of their host, which 
has important implications for vaccine development and the control of pathology.
Acknowledgements.
I would like to take this opportunity to acknowledge and thank all those who have helped and 
supported me over the past 4 years. The biggest thanks go to my supervisor Professor Malcolm 
Kennedy and Dr Catherine Lawrence and Dr Paul Garside, who have guided, supported and 
encouraged me throughout, despite the occasions when they have been pushed to the very limits of 
their patience! And Malcolm, your initial assumptions on the “tree-hugging, hippy crap” sticker that 
mysteriously appeared on your office door were correct. I stand guilty as accused! ! !
My project was made even more memorable due to the other members of the Mary Calder labs 
(namely Anne, Amanda, Chiis, Fiona, Kowther, Lindsay, Liz and Paul) along with st^f and students in 
the Division of Infection and Immunity who made it a happy place to be. The Department of 
Immunology is also acknowledged for allowing the use of equipment, without which parts of the 
project would have been impossible. This was also true for Professor Alan Cooper’s lab in the 
Chemistry Department who allowed me the use of their FPLC -even after I turned one of the columns 
a particularly attractive shade of yellow!
The support I received outside the lab was equally important. Thank-you to Sanya, Pam and Emma for 
being friends and great flat mates, to Morag and Izzy for de-stressing me by dragging me out for runs 
even when I didn’t want to, and Davey, Steph, Clare and Amanda for many alcoholic conversations.
Lastly, and by no means least, I want to acknowledge, thank and dedicate this thesis to my parents, my 
sister Yvonne and Simon for their love, support and understanding, I couldn’t have done it without you 
all.
Ill
Abbreviations
a
a
P
j«Ci
]A
T
%
%
ABF
APC
B cell
Con A
cpm
DTH
dH20
ELISA
FCA
FCS
FIA
g
HAO
anti / alpha 
beta
Micro Curie(s)
Microgramme(s)
Microlitre(s)
Degree celcius 
Percentage point(s)
Tritiated
Ascaris body fluid
Antigen presenting cell
B lymphocyte
Concanavalin A
counts per minute
Delayed type hypersensitivity
Distilled, de-ionised water
Enzyme linked immunosorbent assay
Freund's complete adjuvant
Foetal calf serum
Freund's incomplete adjuvant
Gramme(s) / centrifugal force
Heat aggregated ovalbumin
IV
i
,5I
3
IFNy Interferon-gamma
Ig Immunoglobulin
ÎL Interleukin
kBq Kilo Bequerel
kDa Kilo Daltons
L Litre(s)
LFS Lipopoiysaccharide
mA Milli ampere(s)
mg Milligramme(s)
ml Millilitre(s)
mm Millimetre(s)
mM Millimolar
M Molar
MLN Mesenteric lymph node
MW Molecular weight
OD Optical density
OVA Ovalbumin
p-value Probability value
pABA-1 Parasite-derived Ascaris body antigen-1
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate buffered saline
PEN Popliteal lymph node
PPBS Pharmacia recipe phosphate buffered saline
V
rAB A-1 Recombinant Ascaris body anti gen-1
rpm Revolutions per minute
s.c. Subcutaneously
SEM Standard error of the mean
SPL Spleen
T cell T lymphocyte
TEMED N,N,N’ ,N-tetraethylmethylenediamine
Th T helper lymphocyte
U Units
VI
Table of contents 1
1
Abstract 1
'3■ ‘-’i
Declaration II
%
Acknowledgements III 1
Abbreviations ÏV-VI -
Table of Contents VII-XI
List of Figures XII-XV
1'
Chapter 1 General introduction 1-15
1.1 Background 2
3„:■3.;
1.1.1 The life cycle of Ascaris 2-3 Î
1.1.2 Physical manifestations of ascariasis 3-4 I
1.1.3 The development of immunity 4-5 1
1.2 The role of parasite products on the development of Th2 immune 3:
responses 6 •
1.3 Development of T cell immune responses 6-8
1.3,1 Cytokine influences on Thl/Th2 development 8-9 ■1s
1,3.2 Antigen presenting cells (APCs) 9 -1
1,3.3 Costimulatory molecules 9-10 1■
1.3.4 Antigen dose and ligand-TcR interactions 11-12 3:'■f
1,4 Aims of the thesis 13-14 ■1
1
VII .3
Chapter 2 Materials and methods 16-36
2.1 Animals 17
2.2 Parasites 17
2.2.1 Parasite egg preparations 17
2.3 Parasitological techniques and infections of mice 17-18
2.4 Parasite antigen purification 18-21
2.4.1 Ascaris Body Fluid (ABF) preparation 18
2.4.2 Recombinant ABA-1 purification 18-20
2.4.3 Native protein purification 20
2.4.4 Dialysis and concentration of Ascaris proteins 20-21
2.5 Biochemical techniques 21-23
2.5.1 SDS-Polyacrylamide gel electrophoresis 21
2.5.2 Sample preparation 21
2.5.3 Gel staining 22
2.5.4 Protein estimation (Dye-binding) 22
2.5.5 Protein estimation (Spectrophotometric) 22-23
2.6 Adjuvant assisted immunisations 23
2.7 Sample collection and preparation 23-25
2.7.1 Sera collections 23-24
2.7.2 Cell suspensions 24
2.7.3 Thymidine incorporation assays 24-25
2.7.4 Cytokine production assays 25
2.8 Immunological techniques 25-27
VIII
2.8.1 Enzyme Linked Immunosorbent Assays (ELISA) 25-26
2.8.2 Total immunoglobulin ELISAs 26-27
2.8.3 Antigen specific antibody ELISAs 27
2.9 Heat aggregated ovalbumin preparation 28
2.10 Delayed Type Hypersensitivity induction and measurement 28
2.11 Neutralising anti-interleukin-10 monoclonal antibody treatment in vivo 28-29
2.12 Statistical analysis 29
2.13 Appendix 30-36
2.13.1 General solutions 30
2.13.2 Bacterial culture media 30-31
2.13.3 Protein purification solutions 31-32
2.13.4 Electrophoresis buffers and solutions 32-33
2.13.5 Tissue culture medium 34
2.13.6 ELISA buffers and solutions 35
2.13.7 Stains and fixatives 35
2.13.8 Antibodies & standards used for ELISAs 36
Chapter 3 The immune response to Ascaris suum infection 37-52
3.1 Introduction 38-41
IX
I
4
3.1.1 Helminth infection and immunity 38
3.1.2 Cytokine production and the effect on host immunity to infection 38-39
3.1.3 Cytokine control of protective immune mechanisms 39-40
3.1.4 Experimental design and aims 41
4
I
_  .
3.2 Results 42-45
3.2.1 The immune response generated by Ascaris suum infection
has a Tli2 phenotype 42-43
3.2.2 The immune response against Ascaris suum is influenced by
host major histocompatability complex (MHC) haplotype 44-45
3.3 Discussion 46-47
Chapter 4 The immune response to the Ascaris allergen, ABA-1 53-76
4.1 Introduction 54-56
4.1.1 Parasite products and Th2 response development 54-55
4.1.2 Parasite products and host protection 55
4.1.3 Experimental design and aims 55-56
4.2 Results 57-62
4.2.1 Effect of rABA-1 challenge on the immune response
in Ascaris suum infected mice 57-58
4.2.2 Effects of priming with rABA-1 upon responses to a
subsequent infection with A. suum 59-60
4.2.3 Effect of immunisation with rABA-1 in adjuvants 60-62
4.3 Discussion 63-66
Chapter 5 Immunomodulation by the products of Asc«m 77-122
5.1 Introduction 78-82
5.1.1 Immunomodulation and infection 78-79
X
5.1.2 Helminth product mediated influences 79-80
5.1.3 Experimental design and aims 80-82
5.2 Results 83-94
5.2.1 Ascaris products modulate the immune response against
a heterologous antigen 83-85
5.2.2 Immunomodulation by ABF is dose-dependent 86-87
5.2.3 Parasite-derived ABA-1 cannot influence the immune response 
against OVA and does not contribute towards the effects of ABF 87-88
5.2.4 The ability of ABF to suppress the DTH response cannot be
assigned to a particular fraction of the Ascaris antigens 88-89
5.2.5 ABF-mediated immunosuppression is dependent on the
timing of ABF exposure 89-90
5.2.6 Effect of heat and chemical treatments on ABF and the
implications this for immunosuppression 90-91
5.2.7 Effect of Ascaris antigens on the OVA-specillc response in
IL-4 deficient mice 92-94
5.3 Discussion 95-98
Chapter 6 Discussion and conclusions 123-129
References 130-152
XI
Chapter 4 
Figure 4,1
Figure 4.2
List of Figures
Chapter 1
Figure 1.1 Life cycle of the helminth species Ascaris.
Chapter 3
Figure 3.1 Multiple infections with A. suum influences the cytokine profiles 
of murine mesenteric lymphocytes.
Figure 3.2 Multiple infections with A. suum influences the production of 
antigen-specific inununoglobulins.
Figure 3.3 Total serum IgE concentrations in mice receiving multiple 
A. suum infections.
Figure 3.4 Host MHC haplotype influences the cytokine profile produced 
following Ascaris infection.
Figure 3.5 Host MHC haplotype influences the antigen-specific
innnunoglobulin production following Ascaris infection.
Page No. 
15
15
48-52
48
49
Cytokine production by mesenteric lymphocytes and splenocytes 
of Ascaris suum infected mice challenged with rABA-1. 
Proliferation responses in A. suum infected mice following 
challenge with rABA-1.
XII
50
51
52
67-76
67
68
" 1
a
4
à
'V 
■ A
'1
;a
a,
-|r:
Figure 4.3 Antigen-specific antibody production in A. suum infected mice
following challenge with rAB A-1. 69
Figure 4.4 Cytokine production by mesenteric lymphocytes and splenocytes
of rABA-1-primed mice infected with A. suum. 70
Figure 4.5 Proliferative responses of the mesenteric lymphocytes of mice
primed with rABA-1 prior to A. suum infection. 71
Figure 4,6 Antigen-specific antibody production in rABA-1-primed mice
infected with A. suum. 72
Figure 4.7 IFN-y production by mesenteric lymphocytes and splenocytes
of rABA-1-immunised mice. 73
Figure 4.8 The effects of immunisation with rABA-1 upon proliferation. 74
Figure 4.9 Antigen-specific antibody production in rABA-1-immunised mice. 75
Figure 4.10 Total antibody production in rABA-1-immunised mice. 76
Chapter 5 99-122
Figure 5.1 Ascaris antigens suppress the development of the OVA-specific DTH
response in mice. 99
Figure 5.2 Cytokine production by popliteal lymphocytes of mice exposed
to Ascaris antigens during sensitisation to OVA. 100
Figure 5.3 Ascaris antigens influence antigen-specific proliferation in OVA
primed mice. 101
Figure 5.4 Exposure to parasite antigens during OVA priming influences the
production of antigen-specific immunoglobulins. 102
XIII
I
I
K -S ;:,;
Figure 5.5
Figure 5.6
Figure 5.7
Figure 5.8
Figure 5.9
Figure 5.10
Figure 5.11 
Figure 5.12
Figure 5.13
Figure 5.14
Figure 5.15
Figure 5.16
Polyclonal IgE production in animals exposed to Ascaris antigens 
during OVA sensitisation. 103
ABF suppresses the OVA-specific DTH response in a dose dependent 
manner. 104
The influence of ABF dose and pABA-1 on proliferative responses 
of OVA-primed mice. 105
The influence of ABF dose and pABA-1 on cytokine production 
in OVA-primed mice. 106
The influence of ABF dose and pABA-1 on antigen-specific 
antibody production in OVA-primed mice. 107
The suppression of the OVA-specific DTH response by ABF does not 
require the presence of pABA-1. 108
Separation of ABF proteins by gel fractionation. 109
Both FPLC-purified fractions of ABF suppress the OVA-specific 
DTH response. 110
Cytokine production in the popliteal lymph node cell cultures of mice 
exposed to FPLC-purified fractions of ABF during OVA priming. I l l
Proliferation of popliteal lymph node cells following immunisation with 
FPLC-purified fractions of ABF during OVA priming. 112
Antigen-specific antibody production following exposure to 
FPLC-purified fractions of ABF during OVA priming. 113
Suppression of the OVA-specific DTH response by ABF is dependent 
upon the timing of exposure to the parasite antigens. 114
XIV
I
Figure 5.17 Timing of exposure to ABF and heat or chemical treatments of the
antigens modulates proliferation in popliteal lymph populations. 115
Figure 5.18 Timing of exposure to ABF and heat or chemical treatments 
of the antigens affects in vitro cytokine production by the 
popliteal lymph populations. 116
Figure 5.19 Timing of exposure to ABF and heat or chemical treatments of the
antigens influences production of antigen-specific immunoglobulins. 117
Figure 5.20 The ability to suppress the OVA-specific DTH response by ABF is
unaltered by heating or chemically treatment prior to use. 118
Figure 5.21 The influence of ABF on the development of the OVA-specific
DTH response in IL-4 deficient and anti-IL-10 monoclonal antibody 
treated mice. 119
Figure 5.22 The influence of exposure to ABF during OVA sensitisation
on cytokine production in IL-4 deficient and anti-IL-10 monoclonal 
antibody treated mice. 120
Figure 5.23 The influence of exposure to ABF during OVA sensitisation on
proliferative responses in IL-4 deficient and anti-IL-10 monoclonal 
antibody treated mice. 121
Figure 5.24 The influence of exposure to ABF during OVA sensitisation 
on antigen-specific antibody production in IL-4 deficient 
and anti-IL-10 monoclonal antibody treated mice. 122
XV
CHAPTER 1
GENERAL INTRODUCTION
I
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1.1 Background
Helminth infections, including gastrointestinal nematodes, schistosomes and filarial 
parasites infect more than one billion people world-wide and contribute to one million 
deaths annually (World Health Organisation 1967), and some helminthiases are identified 
amongst the seven infections listed for control or eradication by the World Health 
Organisation (World Health Organisation 1996). Furthermore, helminths impede die 
economic growth in both developed and developing countries through incapacitation of
aworkers and infections of livestock. While helminth infections are in general not
associated with high mortality rates, they can be seriously debilitating and pre-dispose
hosts to secondary bacterial, viral or protozoal infections (Actor et al. 1993), or
compromise host tolerance to self, food and/or other luminal antigens (Rocken et al.
1992a). Both these effects have potentially fatal consequences, so a thorough
understanding of helminth parasite-induced effects upon the host immune system is
.essential for the future development of therapies and vaccines. Within the phylum -'1'
Nematoda, ascaridid and filarial worms are closely related and several species of ascaridid 
are of importance to humans, (genera Toxocara, Anisakis, Baylisascaris and Ascaris) 
(Blaxter 1999). Of all the helminth infections known, one of the most prevalent, infecting ll
one quarter of the world’s population is the roundworm Ascaris lumbricoides (Crompton 
1985), which flourishes in developing countries where poverty, inadequate sanitation, 
limited medical resources and poor health education persist.
?
1.1.1 The life cycle o f A scaris
There are two species of Ascaris, A. lumbricoides which infects humans, and A. suum 
found in pigs. Both species infect their host by the oral route and produce very similar 
disease, characterised by chronicity and malnourishment (Ogilvie and Savigny 1982). ;|
Ascaris spp. are, in general, highly host specific although reports exist of A. lumbricoides 
infecting orang-utans, dogs, cats and sheep (Crompton 1985). Instances of human 
infection however, appear to arise from a reproductively isolated population significantly 
different from those found in pigs (Anderson et al. 1993; Peng et al. 1998). The most
common species reported in the literature with respect to animal models is A. suum. A. 
suum is most prevalent in porcine hosts although it is possible to infect small laboratory
:
l i ;
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rodents (i.e., guinea pigs, rats and mice) and rabbits. However, in the case of small 
animals it is not possible for infections to reach full patency, possibly due to the difference 
in anatomical size between rodents and the natural host (Pawlowski 1982), This means 
that studies of the parasite in laboratory rodents, as reported in this thesis, can only 
investigate the immune response generated by the early stages of infection. A 
diagrammatic summary of the Ascaris life cycle is illustrated in Figure 1.1.
Infection is initiated by the ingestion of infective eggs containing larvae in contaminated 
food (i.e., unwashed vegetables), contaminated drinking water or ingestion of soil by other 
means. Following survival of the acid stomach environment, the larvae hatch in the small 
intestine and penetrate the intestinal wall from where they migrate through the host tissues f  
to the liver and then the lungs from where they emerge into the air spaces and pass into the 
alimentary tract for a second time. Subsequent to the second encounter with the stomach 
the larvae pass into the small intestine where maturation to the adult form occurs allowing 
mating and the production of eggs by females. The eggs as they appear in faeces contain 
undeveloped larvae, and develop to the infective foim outside the host, given appropriate 
oxygen, shade and moisture conditions. The eggs are extremely resistant to adverse 
environmental conditions and chemicals and can remain viable for several years. The time 
scale from initial ingestion to egg production by the adult females in humans is
I
approximately 60 days, (reviewed in Crompton 1985; Crompton 1989). 1
1.1.2 Physical m anifestations o f ascariasis
The physical effects associated with Ascaris infection in humans are linked to the discrete 
stages of the parasite’s life cycle. Symptoms attributable to the larval stages are usually 
acute and affect both the connective tissues and the lungs. Respiratory symptoms begin 5-
■i'6 days post-infection as the newly hatched larvae migrate to the lungs and appear as 
pneumonitis or an asthmatic or type I hypersensitivity response, commonly referred to as I
Loeffler’s Syndrome (Coles 1985; Ogilvie and Savigny 1982). These disturbances can 
persist for up to 10-12 days before giving way to the digestive and nutritional disturbances 
generated by the adult worms (Coles 1985). The adult form of the parasite can cause harm 
ill a variety of ways, either alone or in combination. Firstly, and most commonly, digestive 
and nutritional disturbances arise which are usually chronic. Examples of these include 
colic, nausea, vomiting, malnourishment, lactose intolerance and growth impairment. In 
direct contrast are the acute symptoms, occurring infrequently but are potentially life- 
threatening: intestinal, biliary and pancreatic obstructions and intestinal lesion ruptures. A 
third and final effect results from adults residing in abnormal locations such as the heart, 
nose, ears, lachrymal ducts or the reproductive tract.
As mentioned above, ascariasis is endemic in countries where poverty, inadequate 
sanitation, limited medical resources and poor health education are rife. Prevalence of the 
parasite is decreasing in areas where sanitation has been improved and living standards 
raised, but control can often only be achieved with regular treatments with anti-helmintic 
or “de-worming” medications which cause adult worm expulsion from a host’s 
gastrointestinal tract (Crompton and Pawlowski 1985). However, these drug treatments 
only cure as opposed to prevent infections, and only by educating locals to the dangers of 
these parasites in conjunction with other control measures will limit the re-introduction of 
the parasite to a community. The development of vaccines may require an investigation of 
the invasion and establishment mechanisms employed by these parasites, and the immune 
responses associated with these activities.
1,1.3 The developm ent of im m unity
The development of protective immunity against helminth infections in laboratory animals
requires the presence of CD4^ T cells and is associated with the development of 
eosinophilia, mastocytosis and elevated IgE immunoglobulin antibody (Bancroft et al. 
1994b; Finkelman et a l 1991; McKay et al. 1995; Ogilvie and Savigny 1982). The 
induction of such effector mechanisms has been shown to be controlled by CD4^ T helper
type-2 (Th2) cells and the cytokines they produce, interleukins (ïL)-3, IL-4, IL-5, IL-9, IL- 
10 and IL-13, whose expression is enhanced as a consequence of infection (Finkelman et 
al. 1991). The importance of such immune responses in protective immunity has been 
demonstrated in vivo, where the Th2 response results in clearance of infection, while the 
antithetical T helper type-1 (Thl) response leads to chronic disease (Else et al. 1992b; Else 
and Grencis 1991b).
Of the effector mechanisms induced, eosinophils and IgE have been reported to be central 
to the development of protective immunity against helminths (Sher and Coffman 1992). 
However, immunisation of mice with anti-IL-5 monoclonal antibodies, which reduces total
’Ii!i
:Î
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eosinophil numbers, has been shown to have no effect immunity against Schistosoma 
mansoni, Heligmosomoides polygyrus or Nippostrongylus brasiliensis (Coffman et al.
1989; Finkelman et al. 1991). Furthennore, the value of increased serum IgE as a form of
,protection has been debated for some time now (Allen and Maizels 1996). Depletion of
total IgE by immunisation with anti-IL-4 monoclonal antibodies did not alter resistance to 
S. mansoni in both mice and rats or block worm expulsion in mice infected with N. 
brasiliensis (Sher and Coffman 1992). However, epidemiological support for increased 
total IgE and protection has been provided by studies with Schistosoma haematobium and 
S. mansoni, where resistance to re-infection with these parasites was greater as levels of
IgE increased (Hagan et al. 1991; Rihet et al. 1991). The protective effects of IgE have 
been shown to be blocked by increases in IgG4 antibodies which was associated with 
reduced parasite-induced pathology (Hagan et al. 1991; Hussain et al. 1992), thus 
highlighting the fine balance between protection and pathology in the host. Immunity to A. 
lumbricoides has also been shown to be influenced by the production of IgE; resistance to 
re-infection was associated with high levels of antigen-specific but not polyclonal IgE 
(Hagel et al. 1993; McSharry et al. 1999). Therefore, the development of protective 
immunity against helminths is not only subtle but more complex than initially anticipated.
1.2 The role of parasite products on the developm ent of Tli2 immune 
responses
The features of helminth infections that promote Th2 immune responses are unknown, but 
the induction of IgE and the development of hypersensitivity responses in the host 
suggested that parasite products may have some involvement (Ogilvie and Savigny 1982).
Priming naive CD4^ T cells with extracts of the microfllaiial stage of Brugia pahangi, for 
example, has been shown to enhance IL-5 production upon antigen restimulation (Steel 
and Nutman 1998). While the culture of T cells from individuals with lymphatic fiiariasis 
with the antigens of B. pahangi and Onchocerca volvulus preferentially expanded pre­
existing Th2-like cells (Mahanty et oL 1993).
Helminth products have also been reported to influence antibody production. 
Immunisation with excretory/secretory products of N. brasiliensis can induce the 
production of polyclonal IgE in uninfected mice (Uchikawa et al, 1993). The ability of N, 
brasiliensis products to enhance non-specific IgE has also been demonstrated with 
homogenate of adult worms (Stephan and Konig 1992). Similar effects upon antibody 
production have been reported with larval excretory/secretory products and the adult body 
fluid of A. suum (Lee and Xie 1995; Stromberg 1980). The potentiation of 
immunoglobulin production by helminth products involves antigen-specific antibody 
levels too; immunisation of uninfected mice with a membrane-associated antigen of 
Schistosoma japonicum, which is the pre-dominant target of IgE responses during 
infection, elicited IgE specific for the antigen (Waine et al. 1997). It was therefore 
proposed that this effect was due to the antigen containing signals in its primary amino 
acid sequence, secondary structure or tertiaiy structure, which directed the isotype switch 
to IgE.
1.3 D evelopm ent of T cell immune responses
The discovery by Mosmann and colleagues in 1986 that murine CD4^ T clones could be 
classified into two subsets based upon differences in cytokine secretion patterns
revolutionised understanding of immune responses and disease (Mosmann et al. 1986). 
The two populations described were referred to as T helper 1 (Thl) cells which produced
IL-2, interferon (IFN)-y and tumour-necrosis factor (TNF)-p, and T helper 2 (Th2) cells
which secrete IL-4, IL-5, IL-6, IL-10 and IL-13 (Finkelman et al. 1997; Mosmann and 
Coffman 1989). It has been shown that not only do the cytokines produced by each subset
act as autocrine growth factors, but they also influence the differentiation of CD4^ into 
effectors of the same phenotype (Seder and Paul 1994). Furthermore, the cytokines 
produced by a given T cell subset can regulate the development and activity of cells of the
other phenotype, as illustrated by the inliibition of Th2 cell proliferation by IFN-y and the 
impedance of Thl activation by IL-10 (Fiorentino et al. 1989; Gajewski and Fitch 1990).
The dichotomy described for cytokine production by the two subsets also occurs with 
respect to the effector mechanisms they induce. Thl clones were shown to mediate 
delayed-type hypersensitivity response (i.e., cell-mediated immunity), while Tli2 clones 
provided help predominantly for antibody responses i.e., humoral immunity (Boom et al. 
1988; Cher and Mosmann 1987). Furthermore, differences in the antibody isotype induced 
by the clones were noted with the Thl subset inducing IgG2a, whereas Th2 cells promoted 
IgE and IgGl (Mosmann and Coffman 1989). Taken together, these data appeared to 
explain the differences in immune responsiveness that had been reported for some time to 
occur in diseases such as leishmaniasis and leprosy (Abbas et al. 1996),
The existence of these subsets within the CD4^ T cell populations of humans was much 
more problematic. Early work on T cell clones derived from the peripheral blood of 
healthy donors resulted in populations with a mixed Thl and Th2 response more 
commonly referred to as ThO (Romagnani 1991). However, the demonstration that clones 
derived from patients with autoimmune disease, or those stimulated with bacterial
antigens, produced IFN-y, and those from patients with allergic disease, or stimulated with
7
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excretory/secretory product of Toxocara canis, released IL-4 and IL-5, indicated that the 
selective expansion of discrete Th cell lineages did occur in humans (Romagnani 1994).
1,3.1 Cytokine influences on T h l/T h 2  developm ent
Both Thl and Th2 cells have been shown to develop from the same CD4^ precursor T cell 
that produces mainly IL-2 upon its initial encounter with antigen (Seder and Paul 1994). 
The differentiation of the precursor into either subset is influenced by the manner and 
environment in which it is stimulated. One of the major factors that contributes to this 
process is the cytokine micro-environment of the cell. IL-12, secreted by activated 
macrophages and dendritic cells is the principal Thl-inducing cytokine (Abbas et al. 1996; 
Chan et al. 1991). Activation of macrophages by microbial products tend to stimulate IL- 
12 production and induce Thl-type immune responses (Gazzinelli et al. 1994; Hsieh et al. 
1993). The role of IL-12 in Thl development was highlighted further by the inability of
IL-12 defective mice to produce IFN-y and develop Thl effector responses (Magram et al.
1996). The influence of IL-12 is not only restricted to naive CD4^ populations, but it can 
also act as a co-stimulus to antigen-activated Thl cells to maximise their secretion of IFN-
y (Murphy et al. 1994). The role that IFN-y itself plays in the development of Thl cells is
somewhat more controversial, the addition of neutralising IFN-y antibodies to priming
cultures has been shown to diminish the presence of IFN-y-secreting T cells, suggesting
IFN-y is required for Thl development (Macatonia et al. 1993). However, it has also been
reported in a similar study by another group that neutralisation of endogenous IFN-y in 
priming cultures has no effect (Seder and Paul 1994).
The development of Th2 effector populations depends upon the presence of IL-4 during
priming of CD4'*" T cell precursors both in vivo and in vitro (Le Gros et al. 1990; Swain et 
al. 1990). The fact that IL-4 was necessary for the development of Th2 cells raised the
8 :îir
problem of the source of the cytokine during priming, because IL-4 was thought only to be
produced by T cells post-differentiation. Mast cells, basophils and CD4^ NKl.H T cell 
subset have all been proposed as possible sources of IL-4 (Mosmann and Sad 1996). 
However, the discovery that T cells can produce tiny amounts of IL-4 following initial 
activation has raised the possibility that T cells may be self-sufficient with respect to Th2- 
effector differentiation and development (Schmitz et al, 1994).
1.3.2 Antigen presenting ceils (APCs)
Early work investigating the differentiation of CD4^ T cells suggested that the antigen 
presenting cell (APC) population present at priming may influence the Thl/Th2 fate. 
Gajewski and co-workers demonstrated that while Thl cells responded optimally to 
purified adherent cells from the spleen, Th2 cells proliferated when splenic B cells were 
present (Gajewski et al. 1991). However, in a study using transgenic T cells and peptide 
antigen in order to control for differences in antigen uptake and processing, activated B 
cells and bone-marrow derived macrophages were shown to promote the proliferation of 
both Th subsets equally and that the exogenous cytokine present at priming decided the 
differentiating cells’ fates (Duncan and Swain 1994), and has also been described for 
dendritic cells (Mosmann and Sad 1996). This issue was complicated further by the 
finding that APC-derived IL-6 was capable of polarising naive Th cells to the Th2 
phenotype by stimulating IL-4 production in CD4^ T cells (Rincon et al. 1997). Therefore, 
a role for APCs in Thl/Th2 development and polarisation cannot be overlooked, and, 
indeed, deserves serious consideration.
1.3.3 C ostim ulatory m olecules
A further way in which APCs may influence Thl/Th2 differentiation is through the 
costimulatory molecules that are expressed on their cell surfaces. Effector T cells are 
triggered by the binding of their antigen-specific receptor and CD4 co-receptor to 
peptide/MHC complexes on the APC. However, in order for a naive T cell to proliferate 
and differentiate into the effector population, a second signal is required which is provided
10
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'■f'by the APC costimulatory molecules. The best defined costimulatory molecules known 
are the structurally related B7-1 and B7-2, which bind CD28 on naive T cells and CTLA-4 
on activated T cells (Lenschow et al. 1996). Interestingly, early data reporting that the 
Th2-associated cytokine IL-10 could act upon macrophage APCs to inhibit cytokine 
production by Thl cells was shown to be due to a decrease in the expression of the B7 
molecules (Ding et al. 1993; Fiorentino et al. 1991). The development of both Th subsets
'7'is dependent on costimulation with B7-1 or B7-2 and has been demonstrated in some 
systems to differentially regulate the process (Kuchroo et al. 1995; Lenschow et al. 1995;
A:Seder and Paul 1994). High levels of costimulation have been reported to promote Th2 
responses, probably because increasing the magnitude of initial T cell activation increases 
IL-4 production and the ensuing IL-4-mediated autocrine pathway of Th2 differentiation, ï’ï
while Thl development, which depends more upon the presence of IL-12 in addition to 
some level of costimulation, is less influenced by the magnitude of the T cell response 
these molecules can invoke (Murphy et al. 1994).
The effects of costimulation during a gastrointestinal helminth infection have not been 
extensively studied. However, mice deficient for B7-2 have revealed that while 
interactions between CD28 and the B7-2 molecule are not necessary for the initiation of 
the Th2-associated response, they are required for its progression after the development of 
effector T cells (Greenwald et al. 1999). Other studies have investigated the role of 
CTLA-4 during helminth infections with varying results. CTLA-4, as mentioned above, is 
expressed on activated T cells and also binds the B7 molecules, albeit with a higher 
affinity. Blockade of B7 costimulation with anti-CTLA-4 antibodies has been reported by 
some groups to inhibit the development of optimal Th2 development but not protective 
immunity or the T cell memory response (Harris et al. 1999; Lu et al. 1994), while others 
have reported the only difference observed is an enhancement of the response normally 
seen (McCoy et al. 1997). I:
1.3.4 Antigen dose and ligand-TcR interactions
The effects of varying antigen dose during CD4^ T cell priming and consequently Thl/Th2 
differentiation has been acknowledged for some time, although a dichotomy exists 
regarding whether Thl- or Th2-type responses are evoked by high versus low doses of 
antigen. This effect was first reported by Parish and Liew, where rats were immunised 
with different doses of bacterial flagellin (Parish and Liew 1972). Upon antigen challenge, 
animals receiving very high or very low doses developed strong delayed-type 
hypersensitivity responses. In contrast, those administered with intermediate doses had 
high anti-flagellin antibody responses. Similar effects have also been reported in animals 
infected with Leishmania major and Trichuris muris, where infections with low parasite 
numbers resulted in the development of a Thl-type immune response (Bancroft et al. 
1994a; Bretscher et al. 1992). In contrast, mice that were exposed to low doses of soluble 
protein antigens, via a mini-osmotic pump, developed a Th2-type response (Guery et al.
1996). Furthermore, glutaraldehyde polymerisation of OVA, (which increases molecular 
weight and thus antigen dose), resulted in the development of a Thl response whereas the 
monomeric antigen promoted a ThO-like response (Gieni et al. 1996).
Therefore, the effects of antigen upon the Thl/Tli2 decision may not be dose but its source 
and nature as Thl responses were generated when parasite-derived immunogens were used 
while Th2 responses associated with soluble proteins. An alternative interpretation of 
these results, accounting for the fact that parasite-derived immunogens are unlikely to 
occur at low enough levels to induce a Thl response during a natural infection, is that at 
high antigen doses Thl clones are more susceptible than Th2 clones to activation-induced 
cell death. Therefore, high doses of parasite antigen may promote the expansion of Th2 
cells in the absence of a Thl-mediated negative cross-regulation (Constant and Bottomly
1997).
The involvement of the T cell surface antigen receptor (TcR) in Thl/Th2 differentiation 
was investigated using peptide to prime purified CD4+ T cells from TcR transgenic mice
11
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in vitro (Constant et al. 1995). This eliminated the affinity of the TcR for the antigen as a
%potential variable allowing greater control over antigen dose. It was found that low doses 
of peptide gave rise to Th2-like cells while high doses led to Thl cells. Therefore, high 
densities of MHC class Il/peptide complexes on the surface of antigen presenting cells may 
promote Thl cells through increased TcR engagement, while low densities favour Th2 
cells.
..1Interactions between the TcR and its peptide/MHC ligand may also influence Th cell
"Idifferentiation. Priming mice with the same antigen gave rise to a Thl or Th2 type |
•Iresponse upon challenge, depending on the MHC genotype of the animal (Murray et al.
1989). Although this suggested that the MHC genotype was influencing function through
4:.differences in TcR repertoire, studies in TcR transgenic mice with antigen had
%demonstrated similar effects. Immunisation of mice with an immunodominant peptide of 
the antigen also resulted in the same skewing of the immune response, thus demonstrating 
that the effect was determined by the peptide/MHC class II complex and its interaction 
with the TcR (Pfeiffer et al. 1995). By utilising altered peptide ligands (APLs), this study 7
demonstrated that those peptides which bound well to MHC class II molecules and/or to |
the TcR stimulate development of Thl cells, whereas peptides which bound less well 
favoured Th2 effectors.
It has been proposed that these differences in binding may influence Thl/Th2 development
alter the signals delivered via the TcR after binding, either through signal intensity or types 
of altered signals (Rocken et al. 1992b). Not only have differences in TcR signalling
.1intensity been proposed to influence Thi/Th2 differentiation directly, but it also affects the 
receptiveness of naive CD4 T cells to B7 costimulatory molecules, thus compounding the
"■5involvement of this route in the whole process (Tao et al. 1997).
;1,4 Aims of the thesis
In the present study, experiments were carried out to investigate the effects on the immune 
system of infection with A. suum in mice. Previous research from this laboratory had 
shown that IgG and IgE antibody recognition profiles generated as a result of 
immunisation with Ascaris-denwed products were influenced by host MHC haplotype 
(Kennedy et a l 1991; Tomlinson et a l  1989). Therefore, the contribution that host MHC 
had on other aspects of the immune response following Ascaris infection was investigated.
Increases in IgE immunoglobulin and the generation of hypersensitivity responses in the 
host following infection with helminths brought attention to the influences that the 
products of these parasites may be having on the generation of Th2 immune responses.
This was reinforced by the findings that parasite products could deviate the response
■hphenotype of naive CD4^ T cells as well as preferentially expanding existing Th2 |
Ipopulations and enhancing the production of IgGl and IgE (Mahanty et a l  1993; Steel and 
Nutman. 1998; Stephan and Konig 1992; Uchikawa et a l  1993). Experiments were 
designed to test whether exposure to the products of Ascaris, pseudoceolomic fluid (ABF) 
and the major allergen ABA-1, had any influence on immune response generated following 
parasite infection or could skew the immune response towards a Th2-type phenotype.
I
A final aspect of the immune response associated with helminth infection investigated was
the capacity to modulate immune responsiveness in the host. Immunosuppression or
potentiation is a common feature of many infectious diseases and is considered in some
cases to be mediated by suppressor cell populations, the induction of
hyperimmunoglobulinemia, or by the effects of parasite-derived products (Harnett and
Harnett 1993; Ottensen et a l  1977; Playfair 1982; Poels and Niekerk 1977; Schulz et a l
1998) and can alter the host’s ability to respond to heterologous antigens and pathogens
(Actor et a l  1993; Price and Turner 1986). Similar activities had been reported with
.A^cam-derived products in which exposure resulted in impaired T cell function and 
influenced immunoglobulin production to non-parasite antigens (Ferreira et a l 1995; p
13
Stromberg 1980). The ability to modulate a heterologous immune response by ABF and 
rABA-1 was investigated and the initial steps were made towards elucidation of the 
mechanisms responsible.
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Figure 1 : Life cycle of the helminth species Ascaris
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CHAPTER 2
MATERIALS AND METHODS
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2.1 Animals
Syngeneic female BALB/c mice were obtained from a breeding colony maintained at the 
Central Research Facility, University of Glasgow. Syngeneic female BIO.S and BIO.BR 
mice were purchased from Harlan Olac (Bicester, UK). ÏL-4 deficient mice (129 x
C57BL/6 background) were a kind gift of Dr Allan Mowat, Department of Immunology, 
University of Glasgow. All animals were housed at the Joint Animal Facility, University
of Glasgow under standard animal house conditions. Pelleted CRM breeder diet (Labsure 
Ltd.) and tap water were available ad libitum. All mice were used for experimental 
purposes when 6-8 weeks old.
2.2 Parasites
Adult Ascaris suum were obtained from local abattoirs within 24 hours of host death. The 
worms were washed thoroughly in tap water to remove debris from the host gut and the 
somatic fluids collected as described in section 2,4.1. Female worms were separated from 
the males and then stored in a 5% formalin/Nystatin solution, (see Appendix) at 4“C.
2.2.1 Parasite egg preparations
Uteri were removed from female worms and placed in a flask containing a 5% bleach 
solution. This was incubated for 15 minutes in an orbital shaker at 37°C in order to 
dissolve the uterine walls and release the unembryonated eggs. The eggs were washed 
eight times with dH20 (see Appendix) for 5 minutes at 2000 ipm to remove all traces of 
bleach. To embryonate, eggs were incubated at 26°C, with 5% formalin/Nystatin, for 1 
month and counted weekly to calculate total percentage embryonation. Upon reaching 
70% embryonation the eggs were stored at 4°C in 5% formalin/Nystatin.
3
2.3 Parasitological techniques and infections of mice
Embryonated eggs were washed five times with dH20 as in the previous section and
'I
resuspended in a 5ml volume. The eggs were counted and numbers adjusted to 15000
.embryonated eggs/ml in a 50% dH20/50% 0.1% agarose working solution (see Appendix).
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Animals were infected orally via a gavage needle with 0.2ml of the working solution 
which delivered 3000 embryonated A. suum, eggs per dose.
2.4 Parasite antigen purification
2.4.1 Ascaris Body Fluid (ABF) preparation
The body walls of adult worms were pierced at one end and the body fluid squeezed into a 
siliconised petri dish. The body fluid was transferred into microfuge tubes and centrifuged 
at 13000 rpm for 5 minutes to pellet any cellular debris. The supernatant was carefully 
removed and the total protein concentration quantified using the Bradford Method (see 
section 2.5.4). The Ascaris Body Fluid (ABF) was then stored at -70°C until further use.
2.4.2 Recombinant ABA-1 purification
Recombinant ABA-1 (rABA-1) was produced by culturing E. colU NovaBlue competent 
cells, (Novagen, Cambridge, UK), which had been transformed with a pGEX-lXT
expression vector that contained cDNA coding for ABA-1. Preparation of the pGEX-lXT
expression vector was carried out by Dr Joyce Moore, Wellcome Laboratories for 
Experimental Parasitology, University of Glasgow. rABA-1 was produced as a fusion 
protein with the glutathione S-transferase (GST) of Schistosoma japonicum separated by a 
thrombin cleavage site. The bacterial cells transformed in order to produce rABA-1 were 
named AR4 and are referred to as this subsequently. Throughout the purification process 
bacteria were cultured in the presence of 100/fg/ml ampicillin (Sigma, Poole, UK), to 
select for the transformed population.
A single colony of AR4 was picked from a L-agar stock plate (see Appendix), added to 
100ml of T-broth (see Appendix) and incubated 16-18 hours at 37°C in an orbital shaker.
The culture was then added to IL of T-broth and incubated further until the optical density,
(OD), at 550nm was greater than 1.0. Isopropyl p-D-thiogalactopyranoside, (IPTG;
■ t .Sigma), was added to 0.2mM to induce rABA-1 production and tire cultures were
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incubated for a further 3 hours. Cultures were harvested by centrifugation at 10000 rpm 
and 4“C for 10 minutes. The supernatants were discarded and the bacterial pellets stored at 
-20°C prior to recombinant protein purification.
The bacterial pellets were resuspended in a 40ml total volume of Pharmacia recipe PBS, 
{PPBS; see Appendix), and sonicated on ice at lOpiM amplitude for 30 seconds with a 90 
second cooling period. This cycle was repeated 30 times. The sonicate was centrifuged at 
15000 rpm for 10 minutes at 4°C to pellet cellular debris. The supernatant was retained
with SOOpil of glutathione elution buffer (see Appendix) for 10 minutes at room 
temperature. Five SOOjA fractions were collected as before. All fractions and gel samples 
were stored at -20"C until further use.
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and a 20jA sample removed for SDS-polyacrylamide gel analysis.
IThe GST fusion protein was purified from other E. coli proteins using a GST binding 
chromatography column. 1ml of Glutathione Sepharose-4B slurry (Amersham Pharmacia 
Biotech, St Albans, UK), was prepared as per manufacturers instructions and added to a
Poly-Prep® chromatography column (Bio-Rad Laboratories, Hemel Hempstead, UK; 731- 
1550). The column was equilibrated with 10 ml of PPBS prior to use. The sonicate 
supernatant was applied to the column and the flow-through collected, 20/d of which was 
retained for gel analysis. The column was washed with 15ml of PPBS to flush out 
unbound material and plugged. 25 units of thrombin (Sigma, T6759) in 500/d PPBS was 
mixed with the sepharose and incubated 16-18 hours at room temperature. The eluate was
collected and PPBS added until five 500/fl fractions had been collected from which 20/d 
was sampled for gel analysis. To remove the GST protein the sepharose was incubated
•I
The sepharose column was regenerated by washing the slurry with double bed volumes of 
O.IM Tris-HCl/0.5M NaCl, pH 8.5, and O.IM Na acetate/0.5M NaCl, pH 4.5, (see 
Appendix for both). This was repeated four times. As a final step the column was
,;l
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equilibrated with 10ml of PPBS and stored at 4"C, Each column was used a maximum of 
three times.
The samples retained for gel analysis were run on 17.5% SDS-polyacrylamide gels. The 
fractions observed to contain the 14kDa ABA-1 protein were pooled and analysed on a 
scanning spectrophotometer to estimate the protein concentration.
2.4.3 Native protein purification
ABF was purified using a Pharmacia Superose 12 gel filtration column fitted to a BioRad 
Biologic Fast Performance Liquid Chromatography (FPLC) system. The Superose 12 
column was prepared for use by isocratic flow for 50ml (2 column volumes) with dH20 at
0.1ml minute"! to remove the storage solvent, typically 20% ethanol. The column was 
equilibrated by isocratic flow of FPLC buffer (see Appendix) for 50ml at 0.3ml minute"!. 
All eluents were degassed and filtered using a 0.22/fM sterile filter prior to use. ABF was 
centrifuged at 13000rpm for 10 minutes to remove fine debris before injection. The
purification protocol involved isocratic flow of FPLC buffer for 2ml, injection of 300/^1 of
ABF, followed by isocratic flow of buffer for 30ml. Flow rates of 0.3ml minute"! were 
used resulting in a back pressure in the range 160-180psi.
2.4.4 Dialysis and concentration of Ascaris  proteins
Dialysis of proteins was carried out using Pierce Slide-A-Lyzer™ dialysis cassettes (Pierce 
& Warriner Ltd., Chester, UK) with 10000 MW cut-off membranes. Up to 3ml volumes 
were injected into the cassette using a hypodermic needle attached to a syringe. Samples 
were dialysed with constant stirring at 4"C against a large volume of PBS overnight. 
Volumes of proteins 10ml or above were concentrated using Centricon-10 centrifugal 
concentrators (Amicon Ltd., Stonehouse, UK) with a 10000 MW cut-off. Centrifugation at 
3000 X g was employed In accordance with the manufacturers instructions. Concentration 
of small volumes, typically 3ml or less, was performed using Vivapore 2 concentrators
.
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with a 7500MW cut-off (Vivascience Ltd., Binbrook, UK). Following dialysis and
2.5 Biochemical techniques
2.5.1 SDS"Polyacrylamide gel electrophoresis
The Laemmli gel buffer system was used (Laemmli 1970) to cast 0.5mm thickness gels of
21
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concentration protein estimations were carried out as described in section 2,5.4.
17.5% acrylamide, (see Appendix for buffers and solutions). Glass plates were cleaned 
with 70% ethanol and assembled according to the manufacturers instructions for the 
Hoefer Mighty Small SE245, (Hoefer Scientific Instruments, San Francisco, CA). The 
resolving gel once poured, was overlaid with water saturated butanol to achieve an even
surface during polymerisation. Once polymerised the butanol was removed and the 
stacking gel poured with the correct well formers in place. Upon stack polymerisation the
well formers were removed and the wells thoroughly washed with dH2Û. The gels were 
mounted in the electrophoresis apparatus, Hoefer Mighty Small II, SE250/SE260 and Tris- 
glycine electrophoresis buffer was added to the top and bottom reservoirs. Samples were 
then loaded into the wells. Electrophoresis was normally carried out at a constant current 
of 30mA for approximately 1 hour. Gel tanks were cooled by circulating water at 4"C to 
minimise any gel distortion due to heating during electrophoresis. Upon completion of 
electrophoresis, the gels were removed from the plates and the stacking gels discarded 
leaving the resolving gel ready for staining. Î
2.5.2 Sample preparation
Samples were added to an equal volume of non-reducing sample buffer. Molecular 
weights of bacterial products were estimated by reference to molecular weight marker 
proteins (Amersham Pharmacia Biotech, 17-0446-01) (MW range 14-94 kDa). Spl of the 
reconstituted markers were added to 20/d of non-reducing sample buffer. All samples were 
heated to 100°C for 10 minutes in a Cetus DNA Thermal Cycler 480 (PE Applied 
Biosystems, Warrington, UK) and allowed to cool before loading onto the gel using a 
Gilson automatic pipette.
2.5.3 Gel staining
Protein in electrophoresed gels was visualised by staining with a 0.1% Cooinassie Brilliant 
Blue R-250 solution (see Appendix) for 1 hour with shaking. The gels were destained in 
Coomassie Blue Destain (see Appendix) for 2-3 hours until a clear background was 
obtained. The gels were then dried onto cellophane membrane backing (Bio-Rad, 165- 
0963) on a slab gel dryer (Bio-Rad, 1125B) at 60"C for 1.5 - 2 hours.
2.5.4 Protein estimation (Dye-binding)
A quantitative estimation of total protein concentrations was determined using a 
modification of the Bradford Method (Bradford 1976). The assay is based on absorbance 
shift when the protein assay reagent binds protein in solution. The standard microtitre plate 
variation of the assay was used. Briefly, known protein concentrations ranging between 
20-1500/ig/ml were prepared by diluting a 2 mg/ml stock bovine serum albumin standard 
(Pierce & Warriner Ltd., Chester, UK) in PBS. Test samples were diluted 1/50, 1/100, 
1/500 and 1/1000 in PBS. 5/d of the standards and test samples were added in triplicate to 
a 96 well microtitre plate and 250/d of Coomassie® protein assay reagent (Pierce 
Chemical Co, 23200) added. The absorbance at 595nm was read versus PBS using a MRX 
plate reader (Dynatech Laboratories, Billingshurst, UK). The net absorbance of each 
standard was obtained by subtracting the absorbance of PBS from each sample. A 
standard curve was constructed which was used to determine the protein concentration for 
the unknown samples.
2.5.5 Protein estimation (Spectrophotometric)
A second quantitative method was used to measure the protein concentration of 
recombinant ABA-1 purified from AR4 using a scanning spectrophotometer (Shimadzu, 
UV-1601). Samples to be measured were typically diluted 1/10 with PPBS (see Appendix) 
and absorbance scanned from 300nm through to 230nm. The absorbance value at 280nm, 
A280, was multiplied by the dilution factor. The absorbance, A280, of a 0 .1% solution of 
ABA-1 was calculated using the ProtParam program accessed through the
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ExPASy/SwissProt world wide web site (http://expasy.hcuge.ch/sprot/protparam.html). 
The program calculated the A 280 of the 0.1% solution to be 0.738 based on the amino acid
23
■sequence of ABA-1. This value was used to divide the absorbance of the test sample thus
expressing the protein concentration in mg/ml,
2.6 Adjuvant assisted immunisations
Aluminium hydroxide gel adjuvant, Alhydrogel® 2.0%, (Superfos Biosector, Denmark) 
and Freund's Complete (Sigma, F5881) and Incomplete (Sigma, F5506) adjuvants were 
used to immunise mice in association with various parasite and non-parasite derived 
antigens.
Antigens were adsorbed onto aluminium hydroxide particles, (Alum), by incubating with
rotation at 37°C for 30 minutes. The Alum was centrifuged at lOOOrpm for 5 minutes and
.the supernatants were retained for Bradford method protein estimation (see section 2.5.4). 7
IThis was to ensure all of the protein antigens had adhered to the adjuvant. The solution 
was increased to the original volume by addition of sterile 0.9% saline to ensure each dose
.had an equivalent amount of Alum particles. 4?
Freund’s Complete and Incomplete adjuvant immunisation mixes were prepared by adding 
soluble antigens to an equivalent volume of adjuvant and mixed by either water bath 
sonication or high speed mixing with a Ultra-Turrax T-25 (Janke & Kunkel Laboratories) I
.ÿ,until a stable emulsion formed. An emulsion was deemed stable when a drop of the |7
emulsion was dropped into ice cold PBS and could maintain its structure without dispersal.
4
2,7 Sample collection and preparation
2.7.1 Sera collections
Whole blood was collected by exsanguination via cardiac puncture following the 
sacrificing of mice. Clotting of blood was carried out at 4°C followed by centrifugation at 
13500 rpm for 5 minutes to separate serum from the clot. Overlying serum was collected
by pipetting and transferred to a fresh microfuge tube. Sera samples were stored at -20"C 
until analysis.
2.7.2 Cell suspensions
To prepare suspensions of spleen and lymph node cells suitable for in vitro cytokine and 
proliferation assays mice were sacrificed and the spleens and lymph nodes of mice within 
experimental groups dissected out aseptically and pooled. Organs were dissociated by 
rubbing through a sterile stainless steel sieve using a sterile syringe plunger and collected 
into 10% FCS/RPMI medium (see appendix). Cells were washed by centrifugation at 
1000 rpm for 5 minutes. Pellets were resuspended in 10% FCS/RPMI, passed through 
sterile Nitex mesh (Cadish & Sons, London, UK) to remove cellular debris and washed 
again. The suspensions were counted by light microscope using a haemocytometer and the
cell suspensions adjusted to 1 x 10^ cells/ml by diluting in 10% FCS/RPMI.
2.7.3 Thymidine incorporation assays
1 X 10^ cells, prepared as described in 2.7.2, were cultured with 50/ig/ml ABF, SOpgiml 
rABA-1, 5jUg/ml Concanavalin A, (Con A), (Sigma, C-5275), 5//g/ml lipopolysaccharide, 
(LPS), (Sigma, L-7770), 5/fg/ml Purified Protein Derivative 289 of Mycobacterium bovis, 
(PPD), (Central Veterinary Laboratory, UK) 50//g/ml chicken Ovalbumin Grade V (OVA), 
(Sigma, A-5503) or medium alone in a final volume of 200/d, in triplicate in 96 well flat- 
bottomed microtitre plates (Greiner, Stonehouse, UK). All concentrations given for the 
stimuli are the final concentrations.
Cells were incubated at 37"C in a humidified 5% CO2 atmosphere for 72 hours. At this
time point each well was pulsed with 0.5 pCi (18.5 kBq) of methyl thymidine 
(Amersham Pharmacia Biotech, TRK120) in a 25/d volume of 10%FCS/RPMI. Cells 
were incubated for a further 24 hours after which well contents were harvested onto a 
printed filtermat A (Wallac, UK) using a Wallac 1295-004 Betaplate' '^^ 96-well harvester. 
Filtermats were allowed to dry completely and placed in sample bags to which 10 ml of
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Betaplate Scint (Wallac, UK) was added. The amount of thymidine incorporated by
25
cells was measured by a Wallac 1205 B etaplateliquid  scintillation counter.
2.7.4 Cytokine production assays
Cells were prepared as described in 2.7.2. 7.5 x 10^ cells were incubated in 24 well tissue 
culture plates (Greiner), with 50/^g/ml rABA-1, 50/fg/ml ABF, 5/fg/ml Con A, 50//g/ml 
OVA or medium alone in a final volume of 1.5ml.
Cells were incubated at 37°C in a humidified 5% CO2 atmosphere for 24 or 72 hours. At 
these time points culture supernatants were harvested and centrifuged at 13500 rpm for 5 
minutes to pellet cells. Supernatants were transferred into fresh microfuge tubes to prevent 
cellular contamination of the sample and stored at -20°C prior to cytokine quantification.
2.8 Immunological techniques
2.8.1 Enzyme Linked Immunosorbent Assays (ELISA)
To quantify cytokine concentrations in cell supernatants, capture sandwich ELISAs were
.performed. The supernatants tested were prepared as outlined in section 2.7.4. All buffers 
.and solutions used are listed in the Appendix (section 2.13.6) as are the antibodies (section 
2.13.8). Essentially, 96 well Immulon IV microelisa plates (Dynatech Laboratories) were 
coated overnight at 4°C with 2/^g/ml of monoclonal capture antibody (PharMingen, San 
Diego, CA) in O.IM carbonate buffer, pH 8.2 added at 50/d/well. Plates were washed 
twice for 1 minute with PBS/0.05% Tween-20 and pounded dry on paper towels. Non­
specific protein binding sites were blocked by incubation with 200/fl of PBS/10% FCS for 
1 hour at 37°C. Plates were washed twice as before after which test samples (used neat) 
and standards diluted in PBS/10% FCS were added in triplicate to individual wells in a 
volume of 50/fl and incubated at 37"C for 3 hours. Plates were washed 4 times and 1/fg/ml 
of biotinylated detecting antibody (PharMingen) in PBS/10% FCS added at 50/fl/well. 
Following a 1 hour incubation at 37"C, plates were washed 6 times and 100/d/well of 
streptavidin/peroxidase (SAPU, Carluke, UK) added at a 1/1000 dilution in PBS/10% FCS.
:1
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Following a final incubation at 37°C for 1 hour the plates were washed 8 times before
7addition of 100/d of TMB peroxidase substrate (Kirkegaard & Perry Laboratories, 50-76-
'06) to each well. The light absorbance was then read at 630nm with a reference filter at 
405nm on a MRX ELISA reader (Dynatech Laboratories). Serial dilutions of recombinant 
cytokines were included as standards on each plate and the concentration in the test 
samples calculated from the resulting standard curve using the BIOLINX software package 
(Dynatech Laboratories). 44
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2.8,2 Total imm unoglobulm  ELISAs
Total levels of IgGl, IgG2a and IgE immunoglobulins in the serum of individual mice
Iwere also determined by capture sandwich ELISA. Sera samples were prepared for
analysis as described in section 2.7.1. Buffers, solutions and antibodies used are listed in 
.the Appendix (sections 2.13.6 and 2.13.8). Essentially, 96 well microelisa plates were 
coated overnight at 4°C with 50//l/well of 4/fg/ml (IgGl) or 2//g/ml (IgG2a, IgE) of 
monoclonal capture antibody (PharMingen) in O.IM carbonate buffer pH 8.2. Plates were
4Î4washed twice for 1 minute with PBS/0.05% Tween-20 and pounded dry on paper towels. 
Non-specific protein binding sites were blocked by incubation with 200/ri of PBS/10%
FCS for 1 hour at 37°C. Plates were washed twice as before after which test samples 
(diluted 1/100 with PBS/10% FCS for IgGl and IgE and 1/1000 for IgG2a) and standards 
were added in triplicate to individual wells in a volume of 50/d and incubated at 37"C for 2 
hours. Plates were washed 4 times and 2/fg/ml of biotinylated detecting antibody 
(PharMingen) in PBS/10% FCS added at 50/d/well. This concentration of detection 
antibody was used for all three isotypes examined. Following a 1 hour incubation at 37°C, 
plates were washed 6 times and 100/d/well of streptavidin-peroxidase (SAPU) added at a 
1/1000 dilution in PBS/10% FCS. Following a final incubation at 37"C for I hour the plate 
was washed 8 times before addition of 100/d of TMB peroxidase substrate (Kirkegaard &
Perry Laboratories) to each well. The light absorbance was then read at 630nm with a 
reference filter at 405nm on a MRX ELISA reader (Dynatech Laboratories). Serial
44dilutions of purified antibody were included as standards on each plate and the
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concentration in the test samples calculated from the resulting standard curve using the 
BIOLINX software package (Dynatech Laboratories).
2.8.3 Antigen-specific antibody ELISAs
Levels of antigen-specific IgGl and IgG2a in test serum were determined by a
modification of the capture sandwich ELISA. Sera samples were prepared for analysis as
described in section 2.7.1. Buffers, solutions and antibodies used are listed in the
Appendix (sections 2.13.6 and 2.13.8). 96 well microelisa plates were coated overnight at
4°C with 50/fl/well of 5/<g/ml ABF, rABA-1 or OVA diluted in 0.05M carbonate buffer
.pFI 9.6. Plates were washed twice for 1 minute with PBS/0.05% Tween-20 and pounded 
dry on paper towels. Non-specific protein binding sites were blocked by incubation with 
200/d of PBS/10% FCS for 1 hour at 37"C. The plates were washed twice with 
PBS/0.05% Tween-20 and blocked for 1 hour at 3TC with PBS/10% FCS, 200/^1/well. 
Pooled murine sera from animals seropositive for ABA-1, ABF or OVA and pooled naive
(Kirkegaard & Perry Laboratories) to each well. The light absorbance was then read at 
630nm with a reference filter at 405nm on a MRX ELISA reader (Dynatech Laboratories). 
The amount of antigen specific antibody in a sample was expressed in arbitraiy units as a 
ratio relative to the positive control which was designated numerically as 1.00.
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murine sera were diluted 1/50 with PBS/10% FCS and used as positive and negative 
controls respectively. Test samples were also diluted 1/50 prior to use. All samples and 
controls were added in triplicate to individual wells in a 50/d volume and incubated for 2 
hours at 37°C. Plates were washed 4 times and 2/fg/ml of biotinylated detecting antibody 
(PharMingen) in PBS/10% FCS added at 50/d/well. The same concentration of detection
antibody was used for both antibody isotypes examined. Following a 1 hour incubation at 
37°C, plates were washed 6 times and 100/d/well of streptavidin-peroxidase (SAPU) added 
at a I/IOOO dilution in PBS/10% FCS. Following a final incubation at 37"C for 1 hour the
.s''
plate was washed 8 times before addition of lOOpâ of TMB peroxidase substrate
i
I
ÿ-2.9 Heat aggregated ovalbumin preparation
Chicken Ovalbumin Grade V (OVA), (Sigma, A-5503), was dissolved in saline to give a 
2% ovalbumin solution and incubated in a 100°C water bath for 1 hour to aggregate the g
OVA. The supernatant was removed carefully so as not to disturb the aggregated
ovalbumin and fresh saline added to return the solution to its original volume. This was
0-10mm in 0.1mm intervals (Rohn GB Ltd., Kingston-Upon-Thames, UK; P0C02T). The 
difference between the means of the two measurements gave an index of footpad swelling 
in millimetres which was used for group comparison. Naive animals injected with HAO in
2.11 Neutralising anti- in ter leukin-10 monoclonal antibody treatment in
taken to yield a concentration of 20mg/ml. The solution was then aliquoted into 0.4ml 
volumes and stored at -20°C. Prior to use an aliquot of aggregated ovalbumin was added 
to 3.6ml of saline and placed in a water bath sonicator for 30 minutes, after which 50/el
■was injected subcutaneously into the foot pads of primed animals.
2.10 Delayed Type Hypersensitivity induction and measurement
Groups of animals were injected sub-cutaneously (s.c.) in the left liind footpad with 100/eg 
of OVA emulsified in 50/el of PC A. In some groups ABF, rABA-1, pABA-1 or ABF g
minus pABA-1 were added to the OVA before émulsification. Animals were allowed to 
rest for 7 days before challenge immunisation with 50/el of a 2% heat aggregated
ovalbumin (HAO) solution s.c. in the right hind footpad. Footpad thickness was measured g
,7 ;before and 24 hours after antigen challenge immunisation using dial gauge microcalipers.
,g  :
Ïboth footpads were always included as test controls for non-specific swelling.
wV I V O
■'>To investigate the effects of depleting the cytokine interleukin (IL)-IO on the generation of 
DTH immune responses in vivo, mice were immunised intra-peritoneally with either 200/fg 
of a neutralising rat-anti-mouse IL-10 monoclonal antibody (clone name JES5-2A5) or 
200/ig of a rat IgG isotype control (Sigma, 1-4131) two hours prior to antigen sensitisation. 'II
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Both antibodies were a kind gift of Professor Tim Mitchell, Division of Infection and 
Immunity, Institute of Biomedical and Life Sciences, University of Glasgow.
2.12 Statistical analysis
Results are presented as mean values (x) plus or minus the standard error of the mean 
(SEM) for groups of animals undergoing identical treatment. Differences between groups 
were analysed using a Student’s /-test. As the Student’s /-test assumes normal distribution 
within a population a standard Bonferonni correction was used to control for this factor in 
the experiments described where test groups generally consisted of 5 animals. The 
Bonferonni correction was generated by dividing the probability value (p) of 0.05, the 
assumed upper limit of significance in a /-test, by the total number of /-tests perfoiTned 
within a data set. This decreases the probability of significance for the data set whilst 
correcting for the small sample sizes.
i
2.13 Appendix
2.13.1 General solutions
(a) dH2 0
The distilled, de-ionised water used throughout was produced by a Milli-Q 50 
water purification system (Millipore Ltd., Watford, UK).
(b) 0.9% (w/v) saline 
NaCl
Increase volume to IL with dH20.
9g (Fisher Scientific, UK)
(c) PO4  stock
Na2HP0 4 .12H20
NaH2P04 .2H20
NaCl
Increase volume to IL with dH20.
60g (BDH)
13.6g (Fisher Scientific, UK)
8.5g
(d) Phosphate Buffered Saline, PBS, pH 7.2
PO4  stock 40ml
Increase volume to IL with 0.9% saline and adjust pH to 7.2.
(e) 5% (w/v) sodium bicarbonate
NaHCOs 5g (BDH)
Increase volume to 100ml with dH20 and autoclave prior to use.
2.13.2 Bacterial culture media
(a) T-broth
Bacto-tryptone 
Y east extract
12g (UniPath Ltd.) 
24g (UniPath Ltd.)
3 0
îiI
Glycerol 4ml (Fisher Scientific, UK)
Volume was increased to 900ml with dH20 and the solution was autoclaved. Once 
the temperature of the solution was below 60°C, 100ml of sterile K phosphate was added.
The pH was adjusted to 7.2 with NaOH, the volume increased to IL with dH20 
and the solution autoclaved.
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(b) K phosphate
KH2PO4  23.1g (Fisher Scientific, UK)
K2HPO4  125.4g (BDH)
The volume was increased to IL with dH2Û and autoclaved.
(c) L-broth
Bacto-tiyptone lOg I
Yeast extract 5g
NaCl lOg
(d) L-agar
IL of L-broth was made up as described above. 15g of Bacto-agar (Difco) was 
added to a IL bottle prior to adding the L-broth.
2.13.3 Protein purification solutions
(a) lOX PBS (Pharmacia recipe)
NaCl 81.82g
KCl 2.01g(BDH)
,4
Na2HP04 14.34g
KH2PO4  2.45g
The pH was adjusted to 7.3 and the volume increased to IL with dH20. The 
solution was stored at 4°C and made up to IX PBS with dH2Û prior to use.
'1
The solution was stored at -20'’C.
Na Acetate 4. lOg (Sigma)
NaCl 14.61g
The pH was adjusted to 4,5 with HCl and the volume increased to 500ml with 
dH^O. The solution was stored at 4'’C.
(b) Glutathione Elution Buffer
lOmM Reduced glutathione 0.154g (Sigma, 04251)
50mM Tris-HCl, pH 8,0 50ml
(c) O.IM Tris-HCl/0.5M NaCl, pH 8.5
Tris-HCl 7.88g
NaCl 14.61g
The pH was adjusted to 8,5 with NaOH and the volume increased to 500ml with 
dH20. The solution was stored at 4°C, I
(d) O.IM Na Acetate/0.5M NaCl, pH 4.5
I
(e)FPLC buffer
0.15M NaCl 4,38g
0.05M K2HPO4 4.35g
The pH was adjusted to 7,2 and the volume increased to 500ml with dH20 The 
solution was filtered and degassed prior to use.
2.13.4 Electrophoresis buffers and solutions
(a) Resolving gel buffer, pH 8.8
1.5M Tris 18,15g(BDH)
0.4% SDS 4 ml of 10% (w/v) stock
The pH was adjusted to 8.8 with HCl and the volume increased to 100 ml with
dH20.
7
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(b) Stack gel buffer, pH 6.8
0.5MTris 6.05g
0.4% SDS 4 ml of 10% (w/v) stock
The pH was adjusted to 6.8 with HCl and the volume increased to 100 ml with
dH20.
(c) 10% (w/v) APS
Ig of ammonium persulphate (Sigma) was dissolved in 10ml of dH20. The 
solution was dispensed into 1ml aliquots and stored at -20°C until use.
(d) 17.5% Resolving gels
Resolving gel buffer 
Acrylamide stock
(30% (w/v) Acryl : 0.8% (w/v) Bis) 
dH20
10% (w/v) APS 
TEMED
3.75ml
8.75ml (ScotLab, UK, SL-9208)
2.5ml
100^ /1
lOpil (Sigma, T9281)
(e) 4.75% Stacking gels
Stacking gel buffer 
Acrylamide stock 
dH20
10% (w/v) APS 
TEMED
1.25ml
ISOpil
3ml
50//1
lOpil
(f) 5X Tris-glycine electrophoresis buffer 
Glycine 
Tris-base 
SDS
1440g (Sigma) 
300g (BDH) 
50g
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Increase to lOL with dH20 and dilute to IX prior to use.
(g) Non-reducing sample buffer
10% (w/v) SDS 2ml
Glycerol 1ml
IM Tris, pH 6.8 625//1
1% bromophenol blue lOOjA (Sigma)
Increase volume to 10ml with dH20 and store in foil covered universals to protect 
from sunlight.
(Sigma, M6250).
3 4
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(h) Reducing sample buffer 
As for non-reducing buffer but with the addition of 500/iI of 2-mercaptoethanol
2.13.5 Tissue culture medium
Incomplete RPMI
RPM I1640 powder (Gibco BRL)
25mM Hepes 5.96g (Sigma)
The pH was adjusted to 7.2 using NaOH and the volume increased to IL with 
dH20. The resulting solution was filter sterilised and then under sterile conditions the 
following added:
5mM L-Glutamine 11ml (Gibco BRL)
3.5%NaHC03 5.5ml
O.IM 2-Mercaptoethanol 0.55ml
The medium was then dispensed into 90ml aliquots and stored at 4°C. To complete 
the medium 10ml of heat inactivated Foetal Calf Serum, FCS, (Gibco BRL) was added.
■.Ï,
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2.13.6 ELISA buffers and solutions
(a) O.IM carbonate coating buffer, pH 8.2
NaHCOs 4.2g
The pH was adjusted to 8.2 and volume increased to 500ml with dH20.
(b) 0.05M carbonate/bicai'bonate coating buffer, pH 9.6
Na2C03 2.65g
NaHC03 2.1g
The pH was adjusted to 9.6 and the volume increased to 500ml with dH20.
2.13.7 Stains and fixatives
(a) Coomassie Blue R-250 stain
Coomassie Blue R-250 1 g (Sigma)
Volume was increased to IL with Coomassie Blue destain.
(b) Coomassie Blue Destain 
Methanol 
Acetic acid 
Glycerol
The volume was increased to lOL with dH20.
2.5 L (Fisher Scientific, UK) 
I L  (Fisher Scientific, UK) 
100 ml
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2.13.8 Antibodies & standards used for ELISAs
3
Cytokine/
antibody
ELISA
Capture
monoclonal
antibody
(clone
designation)
Detecting 
monoclonal 
antibody (clone 
designation)
Recombinant 
cytokine 
standard (Cat. 
No.)
Standard curve 
maximum
concentration^
IL-4 l l B l l BVD6-24G2 1923IW 400U/ml
IL-5 TRFK5 TRFK4 19241W lOOU/ml
IL-10 JES5-2A5 SXC-1 19281V 200U/ml
IFN-y R4-6A2 XMG1.2 19301U lOOOU/ml
IgGl Gl-6.5 A85-1
R26-46*
R8-140*
03001D 1/fg/ml
IgG2a R12-4 R19-15 03021D 0.4//g/ml
IgE R35-72 R35-92 0313 ID 2/fg/ml
4
Î;
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4
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^ Indicates the starting concentration of the standard curve used for each ELISA. The 
standard was then diluted through seven doubling dilutions to create the curve.
* Indicates detecting antibodies that were combined in a cocktail for total IgGl ELISAs. 
A85-1 was used for antigen specific IgGl ELISAs only.
I
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All monoclonal antibodies and recombinant standard proteins were purchased from 
PharMingen.
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CHAPTER 3
THE IMMUNE RESPONSE TO AS CARIS  SUUM
INFECTION
I
f
3 7
3.1 Introduction
3.1.1 Helminth infection and immunity
Immunity to parasitic helminth infections is characterised by eosinophilia, mastocytosis 
and increased production of IgE immunoglobulin (Urban Jr. et al, 1992). These responses 
are controlled by an increase in the production of the Th2-associated cytokines interleukin 
(IL)-3 IL-4, IL-5, IL-9, IL-10 and IL-13 (Finkelman et at, 1997). The development of 
protective immunity has an absolute requirement for T lymphocytes, specifically the CD4'  ^
subset; for example, mice vaccinated against Brugia pahangi were unable to control a 
challenge infection as a result of treatment with a depleting anti-CD4 antibody (Bancroft et
not appear to mediate their effects directly on the parasites, but through the induction of 
effector mechanisms by the cytokines they secrete following activation.
■ftal. 1994b; McKay et a l 1995). Although CD4 T cells are vital to host protection, they do
3.1.2 Cytokine production and the effect on host immunity to infection
The intrinsic importance of selective expansion of the CD4^ T cell subsets and the 
development of protective immunity has been demonstrated in a variety of helminth 
infections. BALB/c mice vaccinated with the irradiated larvae of B, pahangi develop 
strong immunity to challenge infections which is characterised by high IL-5 and IL-9,
moderate IL-4 and negligible amounts of IFN-y in mitogen and antigen restimulated spleen
cultures of these animals, accompanied by a significant elevation in parasite-specific IgE 
and peripheral blood eosinophilia (Bancroft et at, 1993). This response phenotype was 
also observed with Trichinella spiralis (Grencis et al, 1991),
The first description correlating CD4^ Th subset activation and the development of 
protective immunity was in work by Else and Grencis with Trichuris muris (Else et al.
1992b; Else and Grencis 1991a). By infecting H-2 compatible strains of mice it was found 
that responder mice which rapidly cleared infection developed a Th2 phenotype with high
levels of IL-3, IL-4, IL-5, IL-9 and low IFN-y production. In contrast, those unable to "■v;::
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expel the parasite develop chronic infections showed the antithetical Thl cytokine profile. 
Development of such responses also promoted differences in the character of the antibody 
response; responder strains generated high IgE and IgGl titres while non-responders had 
high levels of IgG2a. Despite these differences in antibody production it was later shown 
that resistance to infection was not dependent on antibody and that infections could be 
controlled in its absence (Else and Grencis 1996).
Alterations of the adult wonn expulsion phenotypes occurring naturally in mice as a result 
of infection were shown to be reversible by altering the cytokine profile of the host (Else et 
a i  1992a). AKR mice susceptible to T. muris infection were converted to a resistant
phenotype by depleting IFN-y with monoclonal antibodies or by administering a long-
lasting IL-4 formulation made up of the cytokine molecule complexed to a non­
neutralising anti-IL-4 monoclonal antibody. Furthermore, by blocking the functions of IL- 
4 by administering an anti-IL-4 receptor antibody, resistant strains became chronically 
infected and unable to expel the adult worms. IL-4 complexes have also been used in both 
normal and immunodeficient mice infected with Nippostrongylus brasiliensis or 
Heligmosomoides polygyrus (Urban Jr. et al. 1995). In both infections it was found that 
this treatment decreased adult worm fecundity and cured chronic infections but its effects 
were dependent upon the life cycle stage of the parasite at the time of administration.
3.1.3 Cytokine control of protective immune mechanisms
The studies discussed above highlight the importance of selective expansion of CD4'' T 
cells with protection against infection. The differentiation of the T cells results in the 
secretion of specific sets of cytokines, which in turn affect the protective mechanisms 
invoked. The influence of cytokines on the development of anti-helminth protective 
immune mechanisms was first described for IgE production. IL-4 was originally shown to 
be essential for the antibody class-switching to IgE in studies investigating the effects of 
cytokine addition to in vitro cultures of murine B cells which had been stimulated with 
bacterial lipopolysaccharide in order to promote the proliferation and differentiation of the
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cells into plasma cells (Coffman et al. 1986). The presence of IL-4 was demonstrated to 
induce the production of high levels of IgGl and IgE at the expense of the IgG2a and IgG3
subclasses. Furthermore, IFN-y, which is known to be an IL-4 antagonist, enhanced IgG2a
and inhibited both IgGl and IgE (Coffman and Carty 1986; Snapper and Paul 1987). This 
effect of IL-4 was also demonstrated during infections with either N. brasiliensis or H. 
poly gyrus, where injection of anti-IL-4 and anti-IL-4 receptor antibodies blocked the IgE 
responses in both primary and secondary infections (Finkelman et al. 1988). More 
recently, IL-13, a cytokine similar in activity to IL-4, has also been shown to contribute to
'Ianti-parasite immunoglobulin responses (Bancroft et al. 1998).
Increases in total blood and tissue eosinophil numbers is another manifestation of helminth 
.infections and has been associated with the development of debilitating pulmonary hyper­
responsiveness in infected individuals (Hall et al. 1998; Ogilvie and Savigny 1982). In 
many helmintli species this effect has been shown to have a direct relationship to IL-5, a 
cytokine shown to induce the in vitro differentiation of eosinophils from bone marrow pre­
cursors (Finkelman et al. 1990). This was established in vivo by treating N. brasiliensis 
infected mice with neutralising anti-IL-5 antibodies which blocked both tissue and blood 
eosinophilia (Coffman et al. 1989).
:5Cytokine control of mucosal mastocytosis is, in contrast to IgE production and
eosinophilia, a much more complex affair. Not only is IL-4 involved in IgE production but
also it can induce mastocytosis in collaboration with IL-3, a cytokine that also enliances
basopliil production during Stronglyoides venezuelensis infection (Lantz et al. 1998;
Madden et al. 1991). More recently mastocytosis has been shown to be influenced by IL-9
from work using transgenic mice which over-express the cytokine (Faulkner et al. 1997).
.IL-9 transgenic mice have enhanced expulsion of adult T. spiralis which was attributed to 
an increase in enteric mastocytosis. This hypothesis was confirmed by treating the 
transgenics with anti-c-feY antibodies, which depressed the mast cell response and 
prevented worm expulsion.
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3.1.4 Experimental design and aims
In light of the vast amount of data on protective immunity against helminth infections, the 
aims of the experiments presented in this chapter were to investigate the effects of 
infection with Ascaris suum in mice and to establish whether such effects were influenced 
by the number of infections an animal received. To address this groups of mice were given 
a single or multiple infective doses of A. suum eggs orally and the resulting cytokine and 
proliferation responses and antibody production measured. This would reveal if Ascaris 
infection of mice promoted the development of a Th2-type immune response as observed 
with other murine helminth infections. The effects of crude parasite antigens in Ascaris 
primed mice were also investigated by challenging infected animals with Ascaris body 
fluid (ABF) emulsified in Freund’s Complete Adjuvant (FCA). This was to discover if 
exposure to such antigens could modulate the immune response normally observed in the 
mice as a result of infection.
:l
Following on from this, previous studies in which mice were immunised with products of 
Ascaris indicated that the immune response generated was influenced by the host animal’s 
Major Histocompatability Complex (MHC) haplotype (Tomlinson et at. 1989) therefore, 
the effects of host genetics upon the immune response associated with Ascaris infection in 
mice were also investigated. Groups of BIO.S (H-2®), B10.S(9R) (H-2^ "^ ) and C57BL/10
(H-2'^) mice were given multiple oral immunisations with infective A. suum eggs. The 
resulting cytokine and proliferative responses and antibody production were measured to |
assess the effects of host genetics and strain background. Control animals for each strain 7
used were uninfected.
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lOOpig of Ascaris body fluid (ABF) emulsified in Complete Freund’s Adjuvant (CFA) one 
week after the last infection. Seven days after the completion of the infection programmes
42
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3.2 Results
3.2.1 The immune response generated by Ascaris suum infection has a 
Th2 phenotype
The immune response resulting from infection with Ascaris suum was investigated in 
BIO.S mice which had previously been shown to be high IgE responders following 
immunisation with the major allergen of Ascaris, ABA-1 (Tomlinson et al. 1989). Groups
s;of 5 animals were orally immunised 1, 2 or 3 times with 3000 infective eggs of the parasite
Iat weekly intervals. To investigate the effects of crude parasite antigens on primed mice a 7: 
second group, which had received three infections, were challenged intra-peritoneally with
'1
all animals were sacrificed in order to analyse cytokine responses and the production of 
serum immunoglobulins.
&7
Figure 3.1 illustrates cytokine production in the culture supernatants of the mesenteric 
lymph node populations following restimulation with various stimuli in vitro for 72 hours.
I"These populations had been pooled within test groups. Stimulation of cultures with the 
Con A mitogen indicated that the production of IL-4 increased with the number of
infections an animal received. In contrast, IFN-y levels were found to have decreased after
Ï
one infection and were undetectable after two or more doses. Antigen-specific cytokine 
production was found at low levels with IL-4 in the mice given two or more doses of 4
''7infective eggs. Challenge of primed mice with ABF emulsified in FCA reversed the ■'7
cytokine profiles that had been observed for the group receiving the same number of 
infections following restimulation with Con A. IL-4 production was completely ablated
while it was once more possible to detect IFN-y. Neither cytokine was produced as a result J
I
of antigen-specific restimulation. '7
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Antigen-specific immunoglobulin production was measured in the sera of the mice, the 
results of which are shown in Figure 3.2. Measurement of IgGl specific for either ABF or 
rABA-1, the major allergen of Ascaris, showed that while one infection with the parasite 
had no effect upon production, two or more infections significantly enhanced the IgGl 
levels when compared to the uninfected controls (p-value < 0.006), It is also interesting to 
note that in contrast to cytokine production, challenge of mice with the ABF emulsified in 
FCA enhanced the levels of antigen-specific IgGl further. This suggested that despite 
being presented in the context of a potent Thl promoting adjuvant, ABF can continue to
enhance the development of a Th2 immune response. Similarly to IgGl, the pattern of 
IgG2a production was also identical irrespective of antigen-specificity. Whereas one 
infection with Ascaris had no influence upon the levels of antigen-specific IgGl, with 
IgG2a this lead to a significant decrease in production. This depression of IgG2a was 
maintained at the same level as the number of Ascaris infections administered increased. 
However, when mice were challenged with ABF and FCA this resulted in an increase in 
production which was thought to reflect the effects of adjuvant-assisted immunisation.
Levels of total IgE antibody were also measured in the sera as shown in Figure 3.3. It was
found that when the mice were infected once with the parasite it was not possible to detect
any more IgE in the sera as was found in the uninfected controls. However, two
consecutive infections resulted in a significant increase in production, which was maximal
in the group receiving three infections (p-value < 0.006). While levels of antigen-specific 
,antibodies of the IgG sub-classes were found to be enhanced following ABF and FCA 
challenge production of total IgE decreased to levels similar to those observed in the 
double infected animals, indicating that the effects of ABF on boosting the 
immunoglobulin response did not extend to the polyclonal production of IgE.
I
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3.2.2 The immune response against Ascaris suum is influenced by host 
major histocom patability complex (MHC) haplotype
In order to establish whether the MHC haplotype of a host could influence the 
development of the immune response following infection with Ascaris, groups of BIO.S
(H-2®), B10.S(9R) (H-2 '^  ^ and C57BL/10 (H-2^) mice were orally immunised 3 times with 
3000 infective eggs of the parasite at weekly intervals. Control animals for each strain 
were uninfected. Seven days after the third infection all animals were killed in order to 
analyse cytokine production and serum immunoglobulin levels arising from infection. f
Cytokine production in the culture supernatants of mesenteric lymphocyte populations 
restimulated in vitro with Con A is shown in Figure 3.4. The lymphocyte populations used 
had been pooled within test groups, IL-4 production by tlie BIO.S and B10.S(9R) animals 
showed a 6- and 4-fold increase in production respectively as a consequence of Ascaris 
infection. No IL-4 was detectable in either of the cultures from the C57BL/10 mice. IFN-
4
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Y levels were also assessed in the cultures. It was found in the BIO.S mice that IFN-y
levels were completely ablated following parasite infection. This effect was even more
striking in the B10.S(9R) strain where IFN-y production was depressed by 94% from levels
in the uninfected controls that were 10 times greater than those observed in the BIO.S
controls (BIO.S 45.8U/ml; B10.S(9R) 461.8U/ml). In the C57BL/10 mice IFN-y
production was also completely inhibited by infection. Therefore, A. suum does modulate 
the balance of cytokines in these animals although this did not appear to be the case
I
initially when IL-4 production was quantified.
Antigen-specific IgGl and IgG2a production was measured in the sera of the mice as 
illustrated in Figure 3.5. All strains used showed a significant increase (p-value < 0.008) 
in ABF- and rABA-1-specific IgGl following Ascaris infection when compared to their 
appropriate controls. Of the infected animals the BIO.S mice appeared to produce slightly 
higher levels of both antibodies in comparison to the other two strains but the differences I■7
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in production were not significantly different. Analysis of antigen-specific IgG2a levels 
revealed that production was very low and was not significantly altered by infection. The 
exception to this was in ABF-specific IgG2a in the B10.S(9R) mice which had unusually 
high levels of the antibody in the uninfected controls. Following infection in this strain the 
levels were significantly decreased (p-value ^ 0.008) to levels that were equivalent to those 
found in the other strains.
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3.3 Discussion
The data presented in this chapter demonstrate that infection with Ascaris suum promotes 
the development of a Th2-type immune response, as has been reported following infection 
with other helminth species (Finkelman et al. 1997; Urban Jr. et al. 1992). The effects of 
Ascaris infection were initially investigated in BIO.S mice which had previously been 
described as a high IgE responder following immunisation with the products of the parasite 
(Kennedy et al. 1986; Tomlinson et al. 1989). Cytokine production in the mitogen- 
stimulated cultures of the draining mesenteric lymph nodes showed that infection was 
associated with an increase in the production of the Th2 promoter, IL-4 and a decrease in
IFN-y. This effect was shown to be dependent on the number of infections administered
(Fig. 3.1). It was also found possible to reverse the observed cytokine profiles by 
challenging Ascaris primed animals with crude parasite antigen (ABF) emulsified in the 
Thl-promoting adjuvant FCA.
Modifications in the production of antigen-specific immunoglobulins were also noted with 
respect to increasing rounds of parasite infection. Both ABF and rABA-1-specific IgGl 
required a minimum of two infections before a significant increase in production could be 
detected (Fig. 3.2). Again, this effect was directly proportional to the number of 
infections. In contrast, specific IgG2a significantly decreased, an effect associated with 
increased IL-4 (Snapper and Paul 1987). It is interesting to note that while challenge with 
ABF and FCA ablated the production of IL-4 it further increased the production of both 
ABF and rABA-1-specific IgGl, indicating that the parasite antigen is still capable of 
driving this aspect of the Th2 response despite being presented in the context of a potent 
adjuvant. Furthermore, levels of antigen-specific IgG2a were significantly increased as a 
result of challenge emphasising the capacity of the adjuvant to promote Thl responses. 
Analysis of total serum IgE production revealed that, like antigen-specific IgGl, mice had 
to be infected twice in order to exhibit differences in the levels detected (Fig. 3.3). 
Challenge with ABF and FCA depressed production but this was still significantly 
different from the levels observed in the uninfected controls.
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production, the parasite was still altering the Thl/Tli2 balance by blocking the production 
of Thl-associated cytokines.
4 7
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As described earlier, host genetics can have considerable influence on whether the 
immunity induced is protective (Else et al. 1992b; Else and Grencis 1991b). This was 
investigated for Ascaris infection as illustrated in Figures 3.4 and 3.5, Measurement of 
cytokine production by the mesenteric lymphocytes as a result of mitogen restimulation in 
vitro suggested that host genetics could be influencing immune responsiveness. IL-4
'production was highest in BIO.S mice, and approximately ten-fold less in the B10.S(9R) |
strain. C57BL/10 animals did not produce IL-4 at all. IFN-y was also measured in the
cultures and it was found that infection resulted in a 94% decrease in production in the 
B10.S(9R) animals and a complete ablation in both BIO.S and C57BL/10. The effect in 
C57BL/10 was of particular interest as it indicated that while the effects of infection did 
not appear outwardly to promote Th2 development, as indicated by the lack of IL-4
This point was reinforced by the antigen-specific antibody responses. All the strains 
exhibited a significant increase in ABF and rABA-1-specific IgGl following infection 
when compared to the appropriate uninfected controls. The response appeared to be 
slightly higher in the BIO.S animals but this was not statistically different from the levels
found in the other strains. Antigen-specific IgG2a was similarly low in all the groups with
■ r
the exception of the naiveB10.S(9R) mice which had exceptionally high responses. This 
was, however, reduced to levels similar to those found in the other animals following ê  
infection.
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Figure 3.1
M u ltip le  in fec tions w ith  A. suum  in flu en ces  th e  cy to k in e  p ro file s  o f  m u r in e  m esen te r ic  lym p h o cy tes . IL-4 
and IFN-y protein production was assessed in the culture supernatants of mesenteric lymphocytes from BIO.S 
mice following in vitro restimulation for 72 hours. Mice were immunised orally with 3000 infective eggs of A. 
suum as detailed below at weekly intervals. Controls were left unimmunised. Group 5 animals were challenged 
one week after the final A. suum infection with lOOptg ABF emulsified in FCA intra-peritoneally. The animals 
were sacrificed 7 days post-challenge or final infection and the mesenteric lymphocytes within groups pooled. 
Cytokine production was measured using capture sandwich ELISAs.
Group Week 1 Week 2 W eeks Week 4
I D - - - -
2 # - - - 1 X A. suum
3 H - - 1 X A. suum 1 X A. suum
4 # - 1 X A. suum 1 X A. suum 1 X A. suum
5 0 1 X A. suum 1 X A. suum 1 X A. suum IQOfig ABF + FCA
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Figure 3.2
M u ltip le  in fec tio n s  w ith  A. suum in f lu en ces  th e  p ro d u c tio n  o f  an tig e n -sp e c ific  a n tib o d y . BIO.S mice 
received 3000 infective eggs o f A, suum orally as detailed below at weekly intervals. Controls were left 
unimmunised. Group 5 animals were challenged one week after the final A. suum infection with lOOpg ABF 
emulsified in FCA intra-peritoneally. The animals were sacrificed 7 days post-challenge or final infection and 
the sera collected. Antigen-specific immunoglobulins were measured by ELISA. Data are expressed as the 
amount o f antigen-specific antibody in a sample relative to the positive control in arbitrary units. Each data point 
represents the mean ± SEM for an experiment performed in triplicate.
* represents a p-value < 0.006 when compared to group 1 and group 2 using a Student’s t-test.
Group Week 1 Week 2 Week 3 Week 4
1 - - - -
2 - - - I xA.  suum
3 - - 1 X A. suum I X A. suum
4 - I X A. suum I x A .  suum I X A. suum
5 1 X A. suum 1 X A. suum 1 X A. suum lOOpg ABF + FCA
1.5I ABF IgGl
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1 2 3 4 5
1.5
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F ig u re  3 .3
T o ta l s é ru m  Ig E  c o n c e n tra tio n s  in  m ice rece iv in g  m u ltip le  A. siium in fec tio n s. B lO.S mice received 3000  
infective eggs of A, suum orally as detailed below at weekly inteiwals. Controls were left unimmunised. Group 5  
animals were challenged one week after the final A. suum infection with 100/^g ABF emulsified in FCA intra- 
peritoneally. The animals were sacrificed 7  days post-challenge or final infection and the sera collected. Total 
IgE was measured by ELISA. Each data point represents the mean ± SEM for an experiment performed in 
triplicate.
i
■"I
ÎÎ
■ Ç
i |
■ : 4
"
I
represents a p-value ^ 0.006 when compared to group 1 and group 2 using a Student’s t-test.
Group Week 1 Week 2 Week 3 Week 4
1 - - - -
2 - - 1 X A. suum
3 - - I x A . suum 1 X A. suum
4 - 1 X A. suum 1 X A. suum 1 X A. suum
5 1 X A. suum 1 X A. suum 1 X A. suum 100;<gABF+FCA
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Fîgiiic 3.4
H o st M H C  h ap lo ty p e  in fluences th e  cy to k in e  p ro f ile  p ro d u c e d  fo llow ing  Ascaris in fec tion . IL-4 and IFN-y 
production was assessed in the culture supernatants o f mesenteric lymphocytes from BIO.S, BI0.S(9R ) and 
C57BL/10 mice following in vitro restimulation for 72 hours. Mice were immunised orally with 3000 infective 
eggs o f A. suum as detailed below at weekly intervals. Controls were left unimmunised. The animals were 
sacrificed 7 days after the final infection and the mesenteric lymphocytes within groups pooled. Cytokine 
production was measured using capture sandwich ELISAs.
Group Strain MHC haplotype Treatment
1 BIO.S H-2^ -
2 BIO.S H-2^ 3 x 4 .  suum
3 B10.S(9R) H-2" -
4 BiO.S(9R) H-2" 3 x 4 .  suum
5 C57BL/10 H-2’’ -
6 C57BL/I0 H-2’’ 3 x 4 .  suum
MHC haplotype K Ap A . Ep E„ S D L
H-2= s s s (s s) s s s
H-2" s s s s/k k d d d
H-2’' b b b b b b b b
Parentheses represent inability to express the H-2E heterodimer because o f  the defective chain gene. The 
BI0.S(9R) strain will express the I-E molecules as the Eo^ '' gene product is expressed normally and assembles 
with the Ep^ '^  chain on the cell surface.
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Figure 3.5
H o s t M H C  h a p lo ty p e  in f lu e n c e s  th e  a n tig e n -sp e c if ic  im m u n o g lo b u lin  p ro d u c t io n  fo llo w in g  Ascaris 
in fec tion . Groups o f BIO.S, B10.S(9R) and C57BL/10 mice were immunised orally with 3000 infective eggs o f  
A. suum as detailed below at weekly intervals, Controls were left unimmunised. The animals were sacrificed 7 
days after the final infection and the sera collected. Antigen-specific immunoglobulins were measured by 
ELISA. Data are expressed as the amount o f  antigen-specific antibody in a sample relative to the positive control 
in arbitrary units. Each data point represents the mean ±  SEM for an experiment performed in triplicate.
* represents a p-value < 0.008 and § approaching 0.008 when uninfected controls were compared to the Ascaris 
infected animals o f the same strain using a Student’s f-test.
Group Strain MHC haplotype Treatment
1 BIO.S H-2= -
2 BIO.S H-2^ 3 X A. suum
3 B10.S(9R) H-2'4 -
4 B10.S(9R) H-2“* 3 X suum
5 C57BL/10 H-2'’ -
6 C57BL/10 H-2*’ 3 X suum
MHC haplotype K Ap A„ Ep Ea S D L
H-2* s s s (s s) s s s
H-2“’ s s s s/k k d d d
H-2'’ b b b b b b b b
Parentheses represent inability to express the H-2E heterodimer because o f the defective E^ ® chain gene. The 
B10.S(9R) strain will express the I-E molecules as the gene product is expressed normally and assembles 
with the Ep^ chain on the cell surface.
8
-H
0.5
0.4' rABA-1 IgGl
%é  0.3ig 0-2'
u 0.1
0
*
-LzEa.
0.5 ABF IgGl
ï 0.4
A 0.2
0 . 1 -
1 2 3 4 5 6
0.5
0.4
0.3
0.2
0.1
0
$
.7*7.
rABA-1 IgG2a
.... 1.... r ' ""
1 2 2 1 1 1S 4 5 6
”
ABF IgG2a
5 2
CHAPTER 4
THE IMMUNE RESPONSE TO THE ASCA RIS  ALLERGEN,
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4.1 Introduction
4.1.1 Parasite products and Th2 response development IHelminth infections in humans and animais are characterised by the development of strong 
Th2 responses that can induce pathology reminiscent of that observed in atopic disorders.
The features of the infection causing this bias in the T cell response are unknown, but 
suggestions include both the site and route of antigen presentation, activation of cells of the 
non-specific immune response, modification by a physical component of the parasite or 
dose (Liew et al. 1985; Yang et al. 1991). The induction of high levels of IgE 
immunoglobulin and the development of hypersensitivity reactions in the host (Ogilvie and 
Savigny 1982) have drawn attention to the role of parasite products in the development of
gTh2 responses. For example, priming naive CD4^ T cells from healthy, normal individuals 
with filarial-derived antigens in vitro leads to enhanced IL-5 production upon antigen 
restimulation, demonstrating that the antigens can cause deviation of a developing immune 'a
response (Steel and Nutman 1998). Furthermore, filarial antigens have been shown to be
i^n­capable of preferentially expanding existing Th2-like populations in human peripheral
'Iblood ex vivo (Mahanty et al. 1993).
à
Exposure to parasite somatic antigens has also been shown to influence immunoglobulin 
production. B lymphocytes from Nippostrongylus brasiliensisAixîectQd mice exhibit 
enhanced production of IgG and IgE during in vitro culture in the presence of adult worm 
homogenate (Stephan and Konig 1992). This has also been reported in humans where 
normal peripheral blood mononuclear cell cultures exposed to recombinant proteins of 
Onchocerca volvulus produced antigen-specific and polyclonal IgG4 and IgE (Garraud et 
al. 1995). The ability to induce antigen-specific and polyclonal immunoglobulin extends 
to parasite excretory-secretory (E/S) products too. E/S from adult N. brasiliensis can 
promote the production of non-specific IgE that is utilised by parasites as a protective 
mechanism diverting the host defences (Uchikawa et al. 1993). This effect has also been |  
demonstrated with the E/S of Dirofilatia immitis, which in addition to enhancing IgE
% ■ 5
production can also stimulate Th2 cytokine production and the up-regulation of the low 
affinity IgE receptor, FcsIII / CD23 (Yamaoka et al. 1994).
4.1.2 Parasite products and host protection
Besides influencing the differentiation of naive CD4^ T cells and immunoglobulin 
production, parasite products can be employed to induce host protective immunity. One 
approach described for Leishmania major, was to induce tolerance in susceptible mice to 
an antigen of the parasite shown to be the focus of the early immune response, resulting in 
the development of a healer phenotype (Julia et al. 1996). Alternatively, immunisation of 
hosts with the adult homogenates or the E/S products of Trichinella spiralis or 
Heligmosomoides polygyrus either alone or together can protect against subsequent 
infections (Monroy et al. 1985; Silberstein and Despommier 1984). In the case of H. 
polygyrus, however, the development of protection was dependent upon the route of 
antigen presentation, an effect that has also been demonstrated with Leishmania antigens 
(Liew etal. 1985; Mom’oy etal. 1985; Yang etal. 1991).
4.1.3 Experimental design and aims
As discussed, parasite antigens not only influence the development and differentiation of 
Cj^4+ rp but can also aid the generation of protective immunity. Therefore, it was of 
considerable interest whether similar effects could be observed with the products of A. 
suum, particularly the ABA-1 allergen. ABA-1 was selected not only because it has been 
well characterised but it was also readily available as a purified recombinant protein and in 
an enriched form from the paiasite (Kennedy et al. 1991; McReynolds et al. 1993;
Freund’s Complete Adjuvant (FCA) or adsorbed to aluminium hydroxide adjuvant (alum) 
intra-peritoneally. Control animals were challenged with PBS, FCA or alum alone. The
a
Tomlinson et al. 1989). Mice infected orally with A. suum eggs on three occasions were 
challenged with recombinant ABA-1 (rABA-1) either solubilised in PBS, emulsified with
aI
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resulting cytokine, proliferative and serum immunoglobulin responses indicated whether 
rABA-1 had similar effects to Ascaris body fluid (ABF) m Ascaris primed mice.
Another possibility following on from this was that priming with rABA-1 prior to an 
Ascaris infection could modify immune responsiveness, which had been described in other 
systems (Else et al. 1992a). To investigate this, mice were immunised with rABA-1 intra- 
peritoneally either solubilised in PBS, emulsified with FCA or adsorbed to alum. Control
doses of A. suum infective eggs orally before being sacrificed to assess the cytokine 
production, proliferation and immunoglobulin production.
groups were also included for each of the adjuvants. All groups then received multiple
While the preceding experiments investigated the influence that immunisation with Ascaris 
products had on the immune response induced by parasite infection it was not known 
whether exposure to the products themselves could skew the immune response towards a 
Th2-type phenotype. This was addressed by evaluating the immune responses of mice 
primed intra-peritoneally with rABA-1 solubilised in PBS, emulsified with FCA or 
adsorbed to alum and challenged 3 weeks later with lABA-1, in soluble form, emulsified 
in Freund’s Incomplete Adjuvant (FIA), or adsorbed to alum. Control groups were 
immunised with adjuvant or PBS alone.
a
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4.2 Results
4.2.1 Effect of rABA-1 challenge on the immune response in Ascaris  
suum  infected mice
The data presented in the previous chapter demonstrated that challenge of Ajfcarw-infected 
mice with the parasite body fluid, ABF, and adjuvant depressed the anti-Arcar/s immune 
response. However, it was not known whether the ABA-1 allergen of Ascaris, which 
comprises approximately 50% of the total ABF protein (Kennedy and Qureshi 1986), is the 
active principle. To investigate this, groups of BIO.S mice were infected orally with 3000 |
A. suum eggs on three occasions at weekly intervals. Seven days after the third infection 
the animals were challenged with lOOjwg of recombinant ABA-1 (rABA-1) solubilised in
PBS, emulsified with Freund’s Complete Adjuvant (FCA) or adsorbed to aluminium
measured.
Figure 4.1 illustrates the cytokine levels, as measured by capture sandwich ELISA, in the
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hydroxide adjuvant (alum) intra-peritoneally. Control groups were challenged with PBS, I
FCA or alum alone. The mice were sacrificed one week post-challenge in order to analyse 
the cytokine and proliferative responses of the mesenteric lymph node (MLN) and spleen
(SPL) lymphocyte populations. In addition, serum immunoglobulin production was
culture supernatants of MLN and SPL cells that had been restimulated in vitro for 72 
hours. The lymphocyte populations used were pooled within test groups. The Th2- 
associated cytokine ÏL-4 was not detectable in any of the culture supernatants, but 
differences were observed in IL-5 production. In the MLN cultures, it was found that 
challenge with alum alone (group 5) induced tlie highest production of IL-5 following 
stimulation with Con A. Challenge with rABA-1 adsorbed to the alum resulted in a 50% 
decrease in the IL-5 detected, whereas the other groups challenged with rABA-1 exhibited 
increased secretion relative to the controls. In the SPL population, no major differences 
between the groups were found but IL-5 production was approximately three fold less than 
that by the MLN cells. IL-5 could not be detected in either population following culture 
with rABA-1, and ABF-specific IL-5 production was found only in the MLN cultures of I"
7:"
the FCA-rABA~l, alum control and alum-rABA-1 challenged (groups 4 -  6). Analysis of 
IFN-y production revealed that very little of this cytokine was produced by MLN cells as a
result of Con A stimulation with the exception of animals challenged with alum and 
rABA-1. This was also found when the MLN cells were cultured with rABA-1. Systemic
production of IFN-y measured in the SPL occurred in all the cultures but was reduced in
the FCA- and rABA-1-challenged animals. Furthermore, rABA-1-specific IFN-y was 
secreted at high levels following challenge with rABA-1 irrespective of adjuvant used.
The ability of the MLN cells to proliferate following in vitro restimulation are shown in 
Figure 4.2. All groups responded well to stimulation with the T cell mitogen. Con A, 
particularly those challenged with alum alone or mixed with rABA-1 (groups 5 and 6). 
This suggested that immunisation with the Th2 promoting adjuvant could enhance 
proliferation non-specifically. An identical pattern of responsiveness was also observed 
when cells were cultured in the presence of ABF. Levels of rABA-1-specific proliferation 
were enhanced in all the rABA-1-immunised animals and was most pronounced in the 
alum and rABA-1 challenged group. Similar results were found in the spleen (data not 
shown).
Measurement of antigen-specific immunoglobulin production in the mice, (Fig. 4.3), 
revealed that both rABA-1- and ABF-specific IgGl were greatest when the mice were 
challenged with rABA-1 mixed with FCA or alum (groups 4 and 6). Equally, when rABA- 
1-specific IgG2a was measured, an identical pattern was observed, with groups 4 and 6 
producing significantly more of the antibody in comparison to the PBS controls (group 1). 
ABF-specific IgG2a levels approached a significant difference from group 1 only when the 
animals were challenged with FCA and lABA-l. Demonstrating in this instance the ability 
of FCA as a Till response-promoting adjuvant that favours the production of IgG2a 
antibody isotype.
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4.2.2 Effects of priming with rABA-1 upon responses to a subsequent
in the alum, PBS and FCA-rABA-1 immunised groups. Antigen-specific IFN-y was 
detected following restimulation with rABA-1, This was at low levels in the MLN, while
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infection with A. suum
It is known that in some systems exposure to parasite products prior to a homologous S 
infection can modify the immune response observed (Else et al. 1992a). Therefore, mice 
were primed with rABA-1 to investigate if a similar effect could be observed in mice 
infected with A. suum. Briefly, groups of BIO.S mice were immunised with lOO^g of 
rABA-1 intra-peritoneally either solubilised in PBS, emulsified with FCA or adsorbed to 
alum. Control groups were also included for each of the adjuvants. Mice were rested for 
one week before an infection programme with A. suum. Animals were immunised on a 
weekly basis with 3000 A. suum eggs three times. One week after the final infection the 
animals were sacrificed to assess the cytokine production and proliferation of the MLN and 
SPL populations which had been pooled within groups and to collect sera for measurement 
of immunoglobulins.
Cytokine production following in vitro restimulation of the MLN and SPL populations is 1illustrated in Figure 4.4. IL-4 was not detectable in any of the cultures but differences in 
IL-5 were found. In both the MLN and SPL populations IL-5 was only detected when 
populations were stimulated with Con A. IL-5 production was greatest in the MLN when 
mice were primed with soluble rABA-1 (group 2), while all the other groups produced 2 -  |
3 fold less. In the SPL, however the differences in production were not as marked between
3the groups. When IFN-y production was measured a dampening in the levels detected
I
generally was found when mice were primed with the antigen as opposed to challenged.
As described in section 4.2.1, in the MLN the highest levels of Con A-induced IFN-y was Iobserved in the mice immunised with rABA-1 adsorbed to alum. In the SPL, non-specific 
production of IFN-y was maximal not only in the rABA-1 and alum primed mice but also
I
"Priming mice with rABA-1 prior to an Ascaris infection affected the production of antigen-
I
in the SPL the highest production was found in FCA controls, reflecting the Thl-nature of 
the adjuvant (Grim and Maurer 1989), along with the alum and rABA-1 primed.
Examination of both the MLN (Fig. 4.5) and SPL (data not shown), proliferative responses
indicated that all primed groups responded well to culture with the Con A mitogen with the 
.exceptions of those primed with FCA-rABA-1 or alum-rABA-1. The levels of antigen- 
specific proliferation were considerably lower in comparison to the Con A cultures but 
differences were found. Although the alum and rABA-1-primed group’s cultures 
responded poorly following mitogenic stimulation, these were the highest responders 
following stimulation with rABA-1 and ABF.
specific immunoglobulin as shown in Figure 4.6. Exposure to the allergen generally 
resulted in an overall increase in both rABA-1 and ABF-specific IgGl apart from the FCA 
and rABA-1 immunised group’s ABF-specific IgGl which was lower. Levels of rABA-1- 
specific IgG2a were low with little difference between the groups. Although a high 
response was noted in the FCA controls, reflecting the Thl-promoting nature of the 
adjuvant, there was a high degree of variability within the group,
Ï
4.2.3 Effect of immunisation with rABA-1 in adjuvants
7While the priming and challenge of A. suum infected mice with rABA-1, had been shown
. 'j.-, '
to influence the immune response associated with infection, the effects of the allergen in a 
naive, uninfected host were not fully established. This was resolved by inununising groups /
of BIO.S mice intra-peritoneally with either 100//g of rABA-1 solubilised in PBS, f
emulsified with FCA or adsorbed to alum. The animals were rested for 21 days before 
intra-peritoneal challenge with 20pig of rABA-1, in soluble form, emulsified in Freund’s 
Incomplete Adjuvant (FIA), or adsorbed to alum. Control groups were immunised with |
adjuvant or PBS alone. One week post-challenge the mice were sacrificed to investigate
6 0
cytokine and proliferative responses in the MLN and SPL populations which were pooled 
within groups and antibody production in the sera.
Figure 4.7 illustrates the cytokine production in the 72 hour culture supernatants of the 
MLN and SPL populations. Neither IL-4 nor IL-5 could be detected in any of the cultures
and while IFN-y production was detectable this was at very low levels. In the spleen, Con
A-induced IFN-y was detectable only in the cultures of mice immunised with alum-rABA-
1 and following culture with rABA-1. Culturing the SPL cells with rABA-1 revealed that
IFN-y production was greatest in the soluble rABA-1 immunised. Both groups exposed to
FCA (3 and 4), and the alum controls secreted low levels of the cytokine while alum and
rABA-1 resulted in no IFN-y at all. Non-specific IFN-y was produced in all the MLN
cultures apart from the mice receiving rABA-1 in PBS. Addition of rABA-1 to FCA 
resulted in an increase in Con A-stimulated production but this was still not as great as the
levels observed with the alum controls. Antigen-specific IFN-y was detectable in only a
few groups following culture with rABA-1, the strongest response being noted in the 
soluble lABA-l immunised animals.
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Analysis of the proliferative activity by the MLN population in vitro, (Fig. 4.8), showed 
that all groups proliferated strongly following Con A stimulation. Immunisation with the 
FCA or alum adjuvants alone or with rABA-1 suppressed the ability of the MLN
■;population to proliferate when compared to those receiving PBS alone or mixed with
" :'CrABA-1 following restimulation with the allergen. In the SPL, however, exposure to 
rABA-1 with adjuvant boosted this response (data not shown). ABF-specific proliferation 
yielded similar results for both the MLN and SPL cells. Immunisation with FCA with or 
without rABA-1 promoted the strongest responses. Although these differences in the  ^
antigen-specific response were found, overall the ability of the populations to respond was 
considerably lower than the non-specific responses found with Con A.
I'HThe antigen-specific and total immunoglobulin responses generated by immunisation with
rABA-1 are shown in Figures 4.9 and 4.10 respectively. By exposing mice to rABA-1 i.y
either in a soluble foim or mixed with an adjuvant resulted in a significant increase (p- 
value < 0.005), in the production of rABA-1-specific IgGl, IgG2a and ABF-specific IgGl 
in comparison to the PBS immunised controls. The groups that had been immunised with
6 2
either adjuvant and rABA-1 also showed a significant increase when compared to the
'7appropriate controls. Levels of ABF-specific IgG2a, although increased by the presence of
rABA-1, were not significantly different from the PBS or adjuvant controls apart from the 
FCA and rABA-1 group, which was probably due to adjuvant influence. When the total 
levels of IgGl, IgG2a and IgE were assessed it was found that immunisation with alum 
and rABA-1 promoted the highest production of IgGl and IgE, while the production of 
IgG2a was equivalent in all the animals. The effects of alum and rABA-1 together on J  
IgGl and IgE production was found to be significantly greater (p-value ^ 0.005) than when 
the animals were immunised with either component separately.
:%
:
.,7'if-7
1
4.3 Discussion
The results of the experiments presented in this chapter show that immunisation with the 
recombinant ABA-1 allergen of A. suum does influence the immune response associated 
with infection, albeit weakly. By challenging mice with rABA-1 post-infection with 
Ascaris, it was possible to test whether the allergen had similar effects as had been 
described for ABF in the previous chapter (Fig. 3.1). This was assessed through antibody 
production and cytokine and proliferative responsiveness in vitro. Infection with helminth 
parasites is associated with increased production of the Th2-associated cytokine IL-4 
(Urban Jr. et al. 1992), but no IL-4 protein was measurable in the cell cultures of any of the 
experiments performed. The precise reason for this was unknown although possibilities 
include that it was rapidly bound upon secretion by cells expressing its receptor on their 
surface or by secreted soluble receptors. Despite this inability to detect IL-4 differences 
were found in the secretion of IL-5, another cytokine associated with these infective agents 
(Coffman et al. 1989).
The highest levels of IL-5 production in the draining mesenteric lymph node populations 
were found in the Con A-stimulated cultures of infected animals which had been 
challenged with alum adjuvant alone (Fig. 4.1). Interestingly, challenge of mice with 
lABA-l adsorbed to the adjuvant decreased the production of the cytokine by 
approximately half. Systemic production of IL-5 was found only when cultures were 
stimulated with Con A. There were no major differences between the groups’ splenocyte 
cultures with respect to IL-5 secretion although the levels detected were three-fold less 
than those found in the MLN. However, by priming mice with rABA-1 prior to infection 
this decrease in splenic IL-5 was abolished (Fig. 4.4). Production of the Thl cytokine
IFN-y was also found and differences noted. High levels of IFN-y were found in the Con
A and rABA-1-stimulated spleen cultures of the mice challenged with allergen post­
infection (Fig. 4.1). In the rABA-1 stimulated cultures, exposure of mice to the allergen
resulted in a huge increase in IFN-y when compared to those infected and challenged with
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PBS. In the MLN, this was true only of those challenged with alum and rABA-1. In
Icontrast, priming with the allergen before infection (Fig. 4.4) resulted in substantial
decreases in IFN-y detected. This suggested that ABA-1 may be similar to the house dust 
mite allergen, Der p 1, wliich can reduce IFN-y mRNA expression and the frequency of 
IFN-y secreting cells modulating the balance between IL-4 and IFN-y in favour of a Th2
6 4
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response profile (Comoy et aL 1998). I
7"Alterations in the proliferative responses were also noted following immunisation with the
•7.ÏÏrecombinant allergen. Ascaris infected mice challenged witli FCA or PBS alone or mixed
;rwith allergen exhibited reduced levels of non-specific activity following culture with the 
Con A mitogen (Fig. 4.2). A similar effect was noted for both the rABA-1 and ABF- 
Specific responses. In contrast, allergen priming yielded strong non-specific proliferative - 4
responses (Fig. 4.5), although mice exposed to rABA-1 emulsified in FCA were still low 
responders. Interestingly, the other group showing a drop in the Con A stimulated 
response was the rABA-1 and alum primed mice although analysis of the antigen-specific 
responses showed that these animals were the highest responders. This demonstrates that ■Iwhile priming with the allergen depresses non-specific proliferation it does not diminish |  
the enhanced antigen-specific response.
: 7 .;,
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The production of antigen-specific immunoglobulin was reduced slightly when mice were 
primed as opposed to challenged with rABA-1 in the context of Ascaris infection (Fig.
74.6). As expected in both experiments, inclusion of rABA-1 in the immunisation mix 
increased the levels of all rABA-1 and ABF-specific antibody isotypes measured. While 
no significant differences in production were noted for the mice primed with allergen, 
statistical significance was found in the ABA-1 challenged animals as shown in Figure 4.3. 
Challenging infected animals with rABA-1 emulsified in FCA resulted in a significance 
increase in both ABF-specific IgGl and IgG2a and rABA-1-specific IgG2a. While this 
reflected the immune response biasing properties of FCA regarding levels of the Thl-
associated IgG2a isotype (Grun and Maurer 1989), it was interesting that this group 
developed a significant increase in ABF-specific IgGl.
Taken together these data reveal that exposure to the ABA-1 allergen of Ascaris can 
influence the immune response generated by infection although the effects that were 
observed were not as marked as those seen with ABF. Furthermore, comparing the effects 
of immunisation before and after infection demonstrated that both approaches could 
influence the immune response, albeit different aspects.
While analysis of proliferation and cytokine production in the mice showed only slight 
differences, a different picture was seen with antibody production. Significant increases in 
antigen-specific immunoglobulin production were found irrespective of whether
6 5
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The immunisation with rABA-1 with or without adjuvant was used to investigate whether 
the parasite product could deviate the immune response in naive, uninfected mice in favour 
of a Th2-type response as had been described in other systems (Steel and Nutman 1998). 
Figure 4.7 illustrates the cytokine production that was found in the resulting spleen and 
mesenteric lymph node cultures. Not only did immunisation with rABA-1 alone not 
induce IL-4, it was also impossible to detect IL-5, but differences did occur in the
production of IFN-y. In both MLN and SPL cultures it was found that immunisation with
PBS soluble rABA-1 produced the highest levels of rABA-1-specific IFN-y. Examination
of proliferation following re-stimulation with Con A or ABA-1 in these cultures (Fig. 4.8), 
revealed that immunisation with either FCA or alum mixed with rABA-1 decreased 
responsiveness in comparison to the PBS controls and soluble rABA-1 immunised groups. 
These data suggested that while adjuvant-assisted immunisation with rABA-1 had no 
major influence upon the proliferation and cytokine production there was a possible 
influence of contaminating endotoxin in the soluble rABA-1 immunised and PBS control 
groups.
immunisation was assisted by adjuvant (Fig. 4.9). Furthermore, total levels of IgGl and 
IgE were increased significantly by immunisation with alum and rABA-1. This illustrates 
that while iABA-1 is not a significant Th2-promoting parasite product with respect to 
cytokine production it has a significant effect upon immunoglobulin production.
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Figure 4.1
C y to k in e  p ro d u c tio n  b y  m esen te r ic  ly m p h o cy tes  a n d  sp len o cy tes  o f  Ascaris su u m -in fec ted  m ice  ch a llen g ed  
w ith  rA B A -1 . BIO.S mice were infected three times at weekly intervals with 3000 infective eggs of A. suum. 
The animals were challenged 7 days after the last infection, as detailed below. All groups were sacrificed one 
week later. The mesenteric lymphocytes and splenocytes were pooled within groups and cultured in vitro with 
various stimuli as indicated for 72 hours. Cytokine production was measured in the culture supernatants using 
capture sandwich ELISAs. 0 indicates detection limit of assay.
Group Infections Immunisation
I D 3 X Ascaris suum PBS control
m 3 X Ascaris suum PBS + 100/<g rABA-1
3 | 3 X Ascaris suum FCA control
3 X Ascaris suum FCA + 100/<g rABA-1
5 f l 3 X Ascaris suum Alum control
3 X Ascaris suum Alum + 100>(g rABA-1
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Figure 4.2
P ro life ra tio n  re sp o n se s  in  A. suum in fe c te d  m ice  fo llo w in g  ch a llen g e  w ith  rA B A -1 . BIO.S mice were 
infected tliree times at weekly intervals with 3000 infective eggs o f A. suum. The animals were challenged 7 
days after the last infection as detailed below. All groups were sacrificed one week later. The mesenteric 
lymphocytes were pooled within groups and cultured in vitro with various stimuli as indicated for 72 hours. 
Cultures were pulsed with 0.5pCi o f  thymidine and incubated for a further 24 hours before harvesting. Each 
data point represents the mean uptake o f thymidine ±  SEM for an experiment performed in triplicate.
Group Infections Immunisation
1 3 X Ascaris suum PBS control
2 3 X Ascaris suum PBS + lOOpg rABA-1
3 3 X Ascaris suum FCA control
4 3 X Ascaris suum FCA + lOOpg rABA-1
5 3 X Ascaris suum Alum control
6 3 X Ascaris suum Alum + lOOpg rABA-1
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Figure 4.3
A n tig en -sp ec ific  a n tib o d y  p ro d u c tio n  in  A. suum in fec ted  m ice  fo llow ing  c h a llen g e  w ith  rA B A -1 . BIO.S 
mice were infected three times at weekly intervals with 3000 infective eggs o f  A. suum. Animals were 
challenged 7 days after the last infection as detailed below. All groups were sacrificed one week later and sera 
collected. Antigen-specific antibodies were measured by ELISA. Data are expressed as the amount o f antigen- 
specific antibody in a sample relative to the positive control in arbitrary units. Each data point represents the 
mean ± SEM,
* represents a p-value < 0.005 and § approaching 0.005 when compared to group 1 using a Student’s Mest.
Group Infections Immunisation
1 3 X Ascaris suum PBS control
2 3 X Ascaris suum PBS + lOOpg rABA-1
3 3 X Ascaris suum FCA control
4 3 X Ascaris suum FC A + lOOpg rABA-1
5 3 X Ascaris suum Alum control
6 3 X Ascaris suum Alum + lOOpg rABA-1
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Figure 4.4
C y to k in e  p ro d u c tio n  by  m esen te r ic  ly m p h o cy tes  a n d  sp len o cy tes  o f rA B A -l-p r im e d  m ice  in fec ted  w ith  A. 
suum, BIO.S mice were immunised with rABA-1 as detailed below . One week later the animals were infected 
with 3000 infective eggs of A. suum. The mice were infected a total of three times at weekly intervals. All 
groups were sacrificed one week later. The mesenteric lymphocytes and splenocytes were pooled within groups 
and cultured in vitro with various stimuli as indicated for 72 hours. Cytokine production was measured in the 
culture supernatants using capture sandwich ELISAs.
Group Immunisation Infections
I D PBS control 3 X Ascaris suum
2 # PB S+ 100/<g rABA-1 3 X Ascaris suum
3 | FCA control 3 X Ascaris suum
4 # FCA + 100;<g rABA-1 3 X Ascaris suum
s 'H Alum control 3 X Ascaris suum
6 | Alum + 100/<g rABA-1 3 X Ascaris suum
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Figure 4.5
P ro life ra tiv e  re sp o n se s  o f  th e  m esen te r ic  ly m p h o cy tes  o f  m ice p r im e d  w ith  rA B A -1  p r io r  to  A . suum 
in fec tion . BIO.S mice were immunised with rABA-1 as detailed below. One week later the animals were 
infected with 3000 infective eggs of A. suum. The mice were infected a total o f three times at weekly 
intei-vals. All groups were sacrificed one week later. The mesenteric lymphocytes were pooled within 
groups and cultured in vitro with various stimuli as indicated for 72 hours. Cultures were pulsed with 0,5/fCi 
of thymidine and incubated for a further 24 hours before harvesting. Each data point represents the mean 
uptake of thymidine ± SEM for an experiment performed in triplicate.
Group Immunisation Infections
1 PBS control 3 X Ascaris suum
2 PB S+ lOO/ig rABA-1 3 X Ascaris suum
3 FCA control 3 X Ascaris suum
4 FCA + lOOfig rABA-1 3 X Ascaris suum
5 Alum control 3 X Ascaris suum
6 Alum + 100/ig rABA-1 3 X Ascaris suum
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Figure 4.6
A ntigen -spec ific  a n tib o d y  p ro d u c tio n  in  rA B A -l-p r im e d  m ice  in fe c te d  w ith  A . suum. BIO.S mice were 
immunised with allergen as detailed below. One week later the animals were infected with 3000 infective 
eggs of A. suum. The mice were infected a total of three times at weekly intervals. All groups were sacrificed 
one week later and sera collected. Antigen-specific antibodies were measured by ELISA. Data are expressed 
as the amount of antigen-specific antibody in a sample relative to the positive control in arbitrary units. Each 
data point represents the mean ± SEM.
Group Immunisation Infections
1 PBS control 3 X Ascaris suum
2 PBS -t 100/^g rABA-1 3 X Ascaris suum
3 FCA control 3 X Ascaris suum
4 FCA + lOO/fg rABA-1 3 X Ascaris suum
5 Alum control 3 X Ascaris suum
6 A ium + lOO/^g rABA-1 3 X Ascaris suum
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Figure 4.7
IFN -y p ro d u c tio n  by  m esen te r ic  ly m p h o cy tes  a n d  sp len o cy tes  o f  rA B A -1 -im m u n ised  m ice . BIO.S mice 
were sensitised and three weeks later challenged with rABA-1 as detailed below. All groups were sacrificed one 
week post-challenge. The mesenteric lymphocytes and splenocytes were pooled within groups and cultured in 
vitro with various stimuli as indicated for 72 hours. IFN-y protein production was measured in the culture 
supernatants using capture sandwich ELISAs.
Group Sensitisation Challenge
I D PBS control PBS control
2 M PBS + 100><g rABA-1 PBS 4- 20pig rABA-1
FCA control FIA control
FCA + 100}4g, rABA-1 FIA + 20/<g rABA-1
5 # Alum control Alum control
6 # Alum + 100f4g rABA-1 Alum -t- 20j4g rABA-1
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Figure 4.8
T h e  effects o f  im m u n isa tio n  w ith  rA B A -1 u p o n  p ro life ra tio n . BIO.S mice were sensitised and three weeks 
later challenged with rABA-1 as detailed below. All groups were sacrificed one week post-challenge. The 
mesenteric lymphocytes were pooled within groups and cultured in vitro with various stimuli as indicated for 72 
hours. Cultures were pulsed with 0.5pCi o f thymidine and incubated for a further 24 hours before harvesting. 
Each data point represents the mean uptake o f  thymidine ± SEM for an experiment performed in triplicate.
Group Sensitisation Challenge
1 PBS control PBS control
2 PBS + lOOfig rABA-1 PBS + 20pg rABA-1
3 FCA control FIA control
4 FCA + lOOpg rABA-1 FIA + 20pg rABA-1
5 Alum control Alum control
6 Alum + lOOpg rABA-1 Alum + 20pg rABA-1
Medium Con A
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Figure 4,9
A n tig en -sp ec ific  a n tib o d y  p ro d u c t io n  in  rA B A -l- im m u n ise d  m ice. BIO.S mice were sensitised and three 
weeks later challenged with rABA-1 as detailed below. All groups were sacrificed one week later and sera 
collected. Antigen-specific antibodies were measured by ELISA. Data are expressed as the amount o f antigen- 
specific antibody in a sample relative to the positive control in arbitrary units. Each data point represents the 
mean ±  SEM.
* represents a p-value < 0.005 when compared to group 1 (PBS controls), § when compared to group 2 (FCA 
controls) and # when compared to group 5 (Alum controls) using a Student’s /-test.
Group Sensitisation Challenge
1 PBS control PBS control
2 PBS + lOOpg rABA-1 PB S+ 20pg rABA-1
3 FCA control FIA control
4 FCA + lOOpg rABA-1 FIA + 20pg rABA-1
5 Alum control Alum control
6 Alum + lOOpg rABA-1 Alum + 20pg rABA-1
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Figure 4,10
T o ta l a n tib o d y  p ro d u c tio n  in  rA B A -l- im m u n ise d  m ice. BIO.S mice were sensitised and challenged three 
weeks later with rABA-1 and adjuvants as detailed below intra-peritoneally. All groups were sacrificed one 
week later and sera collected. Total IgG l, Ig02a and IgE levels were measured by ELISA. Each data point 
represents the mean ±  SEM.
* represents a p-value < 0.005 when compared to group 1 (PBS controls), § when compared to group 2 (FCA 
controls) and # when compared to group 5 (Alum controls) using a Student’s t-test.
Group Sensitisation Challenge
1 PBS control PBS control
2 PBS + lOOpg rABA-1 PBS + 20pg rABA-1
3 FCA control FIA control
4 FCA + lOOpg rABA-1 FIA + 20pg rABA-1
5 Alum control Alum control
6 Alum + lOOpg rABA-1 Alum + 20pg rABA-1
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CHAPTER 5
IMMUNOMODULATION BY THE PRODUCTS OF ASCAR7S
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5.1 In trod u ction
which secreted high levels of Transforming Growth Factor p (TGF-P) (Bridoux et al.
secreting or T helper 3 (ThS) cells in the regulation of mucosal immune responses 
(Fukaura et al. 1996; Neurath et al. 1996).
The development of a Th2 response due to helminth infection has been demonstrated to 
modulate responsiveness to both non-parasite antigens and other pathogens in infected
5.1.1 Im inunom odulation  and in fection
A feature that is common to many infectious diseases is modulation of the host immune 
response which can be either specific or non-specific. Early studies suggested that 
immunomodulation was mediated by a suppressor cell population, particularly 
macrophages or T lymphocytes. Suppressor macrophages were shown to mediate their 
effects non-specifically interfering with mitogen responses or primary antibody responses 
to both T cell dependent and independent antigens (Cunningham and Kuhn 1980). 
Conversely, suppressor T cells which were more specific in their activities were proposed 
by some to be important in detennining disease outcome (Playfair 1982). In recent years, 
the concept of suppressor T cell populations has been replaced by one of regulatory T cells 
following the establishment of the T helper 1 (Thl)/Th2 model for CD4  ^ T cells. Many 
studies have described such regulatory populations that are associated with, but are distinct 
from, Th2 cells (Bridoux et al. 1997; Groux et al. 1997; Fowrie et al. 1996). For example, 
CD4^ T cells, which develop in an IL-10 rich environment, give rise to a subset that 
secretes high levels of IL-10 and little lL-2 and IL-4 (Groux et al. 1997). These T 
regulatory 1 (Trl) cells can inhibit the development of colitis in immunodeficient mice and 
the in vitro activation of T cells and have been described in humans and mice. Another 
subset of CD4^ T cells expressing low levels of the transmembrane molecule CD45RB 
which could also inhibit colitis and T cell mediated autoimmune disease was described
1997; Fowrie et al. 1993a; Fowrie et al. 1996). Further studies by other groups 
investigating oral tolerance have highlighted the importance of these CD4^ TGF-(3-
-ft,
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animals and humans (Curry et al. 1995; Hermanek et al. 1994; Price and Turner 1986). 
Although this can leave the host vulnerable to secondary infections (Actor et al. 1993), it
generation of such responses down-regulates protective immunity to other pathogens, such 
as protozoan parasites, is unclear but has been linked to the innate chronicity of the
response in their favour (Pastrana et al. 1998).
:
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can also confer protection against an otherwise fatal disease (Yan et al. 1997). How the
helminth itself.
i
5.1.2 Helminth product mediated influences
The ability to alter immune reactivity has also been described following exposure to 
parasite antigens and excretory-secretory (E/S) products. Parasite products mediate their 
effects through a variety of mechanisms. The suppression of B and T cell proliferation 
described during infection (Ottensen et al. 1977; Piessens et al. 1980), can be mediated by 
parasite products through altering levels of intracellular signalling molecules (Harnett and 
Harnett 1993), targeting signalling pathways (Deehan et al. 1998), or inducing suppressor 
populations (Allen and MacDonald 1998). Conversely, with some parasite species, the 
products may enhance proliferation non-specifically, which in the case of H. polygyrus,
âoccurs independently of the MHC, suggestive of superantigen-like properties (Robinson et 
al. 1994). Helminth products with protease activity or which inhibit host proteases have 
been described in the literature; these have a diverse effect on the immune response 
ranging from disruption of the MHC class II antigen processing pathways (Bennett et al.
1992), and modulation of T cell effector functions (Ham^ima et al. 1994), to cleavage of S:
essential B and T cell surface molecules (Schulz et al. 1998). Furthermore, parasites can i; 
secrete human cytokine homologues, creating the potential to divert a developing immune
4Products derived from Ascaris suum have also been shown to be immunomodulatory. 
Soluble antigen obtained from third stage A. suum larval culture medium and adult body
"v;'i■I--fluid have been demonstrated to potentiate IgE antibody response to ovalbumin in rodents 
(Lee and McGibbon 1993; Stromberg 1980). However, the role of the adult worm
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homogenate in IgE production is contentious with some groups claiming it boosts IgE 
levels whilst others claim the reverse (Lee and McGibbon 1993; Soares et al. 1992). T cell 
function impairment has also been reported in connection with Ascaris extracts 
demonstrating that the effects of this parasite are not exclusive to immunoglobulin 
production (Ferreira et al. 1995).
5.1,3 Experimental design and aims
As described, imraunomodulation is a common feature of many infections and can affect a 
host’s ability to respond to heterologous antigens and pathogens. With helminth infections 
the parasite products can mediate these effects, therefore, it was decided to investigate 
whether the products of Ascaris, ABF and ABA-1, behaved similarly by analysing their 
effects on the development of the delayed-type hypersensitivity (DTH) response against 
chicken egg ovalbumin (OVA) in mice. The DTH reaction was measured using the 
footpad swelling test and is primed for by sub-cutaneous immunisation with OVA 
emulsified in Freund’s Complete Adjuvant (FCA) in the left hind footpad. Animals were 
challenged one week later with soluble heat-aggregated OVA (HAO) in the opposite rear 
footpad. This gives rise to an inflammatory response usually visible at 16 to 24 hours post­
challenge which has been reported to be mediated by T helper 1 CD4+ cells (Cher and 
Mosmann 1987).
Firstly, in order to establish whether the Ascaris antigens, ABA-1 and ABF, could 
modulate the immune response noimally observed in the OVA-DTH model in the mouse, 
animals were sensitised with OVA either alone or mixed with ABF or rABA-1 and 
challenged with HAO. Further groups were primed and challenged with Ascaris products 
alone to control for the ability of the parasite antigens to induce DTH responses 
themselves. A control group consisting of 3 animals was immunised in both feet with 
HAO at the time of test challenge to compensate for non-specific swelling resulting from 
the procedure.
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Subsequently, the aims of the remaining experiments presented in this chapter were to 7
.1elucidate the mechanisms involved in the any immunomodulatory activities of the Ascaris 3
■products and identify components that were directly involved. 1
s
To investigate whether the dose of ABF used at priming was important for modulating the 
OVA-specific DTH response, mice were sensitised with OVA alone or mixed with varying 
doses of ABF. Mice were challenged with HAO and the resulting DTH response
4measured. One week post-challenge, mice were killed to analyse cytokine, proliferative 7
dand serum immunoglobulin responses, which was performed in all the experiments
%presented.
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While the two previous experiments examined the effects of Ascaris antigens during the 
sensitisation phase of the DTH model it was of interest if a similar phenomenon occurred 
in an established immune response. Therefore, mice were primed with OVA and 
challenged 7 days later with HAO mixed witli ABF. The resulting DTH and inunune 
responses were compared to animals primed with OVA alone or mixed with ABF and 
challenged with HAO only, thus indicating the stage in an immune response where the 
influence of ABF was maximal.
■I
In order to identify the components of ABF with inununomodulatory activities, ABF was 
applied to a gel filtration column which separated the body fluid into parasite derived 
ABA-1 (pABA-1) and two ABF protein peaks, named peak 1 and peak 2 respectively.
Mice were sensitised with OVA alone or in addition to the unfractionated ABF, pABA-1, 
fractionated ABF with the pABA-1 removed ABF peak 1 or ABF peak 2. Challenge 
occurred seven days later with HAO. This experiment addressed firstly whether pABA-1 
was similar to rABA-1 in activity, secondly, did the effects of ABF require the presence of 
pABA-1 and thirdly, could the ability to deviate the immune response be assigned to a 
particular subset of ABF’s proteins. ' I
7
Previous studies on immunosuppressive proteins produced by another gastrointestinal
nematode described the effects of extreme heat and pH on the stability of the
immunomodulatory properties of the proteins (Pritchard et al. 1994). A similar approach 
was employed to investigate the stability of ABF’s proteins that had displayed these 
characteristics. ABF that had received heat or acid treatments prior to use were mixed 
with OVA and used to immunise mice. Seven days later the mice were challenged with 
HAO to investigate if the proteins in ABF were susceptible to such treatments. While this 
set of experiments was designed to investigate the role of the protein molecules of ABF in 
immunomodulation, they did not rule out the influence that other groups of molecules e.g., 
glycolipids or carbohydrates, may have in this model.
The final set of experiments addressed the issue that ABF may mediate its effects by 
promoting the production of Th2 cytokines in the naive, uninfected host. Mice deficient
for the Th2 associated cytokine IL-4 and control animals were treated systemically with a 
neutralising monoclonal antibody against lL-10 or an isotype control prior to immunisation 
with OVA alone or mixed with ABF. Challenge occurred 7 days later with HAO. These 
experiments investigated the influence of both IL-4 and IL-10 in the modulation of DTH 
responsiveness and whether they mediated their effects alone or in synergy, which had 
been described in another model system (Powrie et al. 1993b).
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is H-2^). To confirm this finding, further experiments encompassing a wider range of host 
haplotype would be required. Marked differences in responsiveness between the mouse
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5.2  R esults
5.2.1 Ascaris  products modulate the immune response against a 
heterologous antigen
In order to investigate whether Ascaris products could modulate the footpad DTH response 
against OVA, experiments were carried out in BALB/c mice. Groups of 5 animals were 
sensitised in the rear footpad with lOOpg OVA, either alone or mixed with SOOpg ABF 
protein or lOOpg rABA-1. To investigate whether the Ascaris products induced a DTH 
response themselves, further groups were immunised with SOOfig ABF or lOQpg rABA-1 
alone. All antigens were emulsified in Freund’s Complete Adjuvant (FCA) and 
administered in a SQjA volume. Mice were challenged 7 days later in the opposite rear 
footpad with either 100//g heat-aggregated OVA (HAO), 250/fg soluble ABF or 100/fg 
soluble rABA-1. A control group consisting of 3 animals was immunised in both feet with 
HAO at the time of test challenge to compensate for non-specific swelling resulting from 
the procedure. Footpad thickness was measured before and 24 hours after antigen 
challenge. The difference between the means of the two measurements gave an index of I
footpad swelling in millimehes, which was used for group comparison. The results of this 
experiment are illustrated in Figure 5.1a.
I
Sensitisation and challenge with OVA alone resulted in a pronounced thickening of the
:challenge footpad (group 1) indicative of DTH generation. Mixing of OVA with the 
recombinant form of the Ascaris allergen, ABA-1, at priming (group 3) had no significant
;effect on the development of the OVA-specific DTH response. In contrast, when animals
were sensitised with OVA mixed with ABF (group 2), a complete ablation of the OVA-
specific response occurred (p-value ^ 0.001), Identical effects following sensitisation with
the Ascaris antigens were also observed when this experiment was performed in BIO.S
.mice (Figure 5.1b), suggesting that the immunomodulatory properties of ABF are not 
MHC restricted as the strains used had disparate haplotypes (BALB/c is H-2^ while BIO.S
strains were found following sensitisation and challenge with ABF or rABA-1 alone. 
While BIO.S mice did not generate DTH responses against ABF and rABA-1, BALB/c 
mice developed strong responses, which although not as great as the response to OVA 
alone were not significantly different. The reasons for the development of such a response 
in BALB/c and not BIO.S mice aie unknown and would require further investigation.
Cytokine production by the draining popliteal lymph node (PLN) cells were analysed by 
capture sandwich ELISA, the results of which are shown in Figure 5.2. DTH is an
inflammatory response, associated with the production of cytokines such as IFN-y (Cher I
and Mosmann 1987). All groups produced IFN-y following restimulation with the T cell
mitogen Concanavalin A (Con A) and this was greatest in those mice sensitised with OVA 
alone or mixed with ABF (Figure 5,2a). Of particular interest were the levels of OVA-
specific IFN-y, which were maximal in the mice exposed to OVA alone or in addition to
rABA-1 during priming. While rABA-1 had no effect on the OVA-specific IFN-y, the
1presence of ABF during sensitisation resulted in a decrease in the production of the 
cytokine. Other helminth antigens have been reported to alter immune responsiveness by 
promoting the production of Th2 associated cytokines, e.g., IL-4, IL-5 (Mahanty et a l
1993; Steel and Nutman 1998). Therefore the decrease in OVA-specific IFN-y observed
following sensitisation with ABF could have been due to the Ascaris antigens promoting
the production of tliese cytokines at the expense of IFN-y. However, no IL-4 or lL-5 could
be detected in any of the supernatants. Interestingly, differences were found in the levels 
of IL-10, a cytokine suggested to mediate the balance between inflammation and humoral 
immunity (Fiorentino et al. 1991; Mosmann and Moore 1991; Rousset et al. 1992). Figure 
5.2b illustrates that IL-10 production was comparable in the mitogen restimulated cultures 
from animals sensitised with OVA alone or mixed with rABA-1, but a doubling occurred 
following exposure to ABF during priming. OVA-specific IL-10 production occurred 
slightly when OVA was mixed with rABA-1 but this was minimal when compared to
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priming with OVA and ABF. Interestingly, no OVA-specific IL-10 was produced as a 
result of exposure to OVA alone.
The proliferative responses of the PLN cell cultures following antigen restimulation in 
vitro, are shown in Figure 5.3. All groups responded well following stimulation with Con 
A. Stimulation with either ABF or rABA-1 promoted proliferation in those groups 
sensitised with the Ascaris antigens. The OVA-specific proliferative response was 
identical in the groups that had been primed with OVA alone or mixed with rABA-1. 
However, in contrast to that which had been observed with DTH responsiveness and 
cytokine production, exposure to ABF during sensitisation boosted the OVA-specific 
proliferative response.
A final aspect of the immune response that was investigated was whether ABF modulated 
the associated humoral response. Antigen-specific IgGl and IgG2a and total IgE titres 
were measured in the sera samples collected 7 days post-challenge, the results of which are 
shown in Figures 5.4 and 5.5. The pattern of production of OVA-specific antibodies was 
similar for both the IgG sub-classes. As seen previously, exposure to rABA-1 during 
priming had no effect on the course of OVA-specific immunity, while ABF significantly 
reduced the levels of IgG2a (p-value < 0.007) and to a level approaching significance for 
IgGl, An unexpected finding was that mice which had been immunised and challenged 
with rABA-1 alone, produced large amounts of OVA-specific IgGs. While ABF-specific 
antibodies were detected in all the groups immunised with either of the Ascaris antigens, 
rABA-1-specific production occurred only in the groups exposed to the allergen. 
Measurement of total IgE production revealed that the highest titres were seen in those 
groups 2 and 3 that were immunised with ABF or rABA-1 in conjunction with OVA and 
HAO challenged. Surprisingly, IgE levels in groups which had been immunised with the 
Ascaris antigens were equal to or less than the titres in animals immunised and challenged 
with OVA alone.
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5.2 .2  Im m iinom odulation  by ABF is dose-depend en t
In order to investigate whether the ABF-mediated modulation of the OVA-specific DTH 
response was affected by the amount of ABF, BALB/c mice were immunised as in section 
5.2.1 with 100//g OVA, alone or mixed with varying doses of ABF. Seven days after 
immunisation, mice were challenged with 100/fg HAO and DTH responsiveness was 
measured. One week post-challenge, mice were killed in order to analyse cytokine and 
proliferative responses in the PLN population along with immunoglobulin production in 
the serum. The results of this experiment are shown in Figures 5.6 -  5.9.
albeit unknown, is specific.
IFN-y levels. Non-specific IFN-y production was greatly enhanced in mice which were
immunised with 250ffg ABF (group 3; lOOOU/ml) in comparison to the groups exposed to 
SOOpig (group 2; 356U/ml) or 50pg (group 4; 132U/ml). As observed with the OVA-
The development of the OVA-specific DTH response was suppressed significantly (p-
value < 0.001), when mice were exposed to 500 or 250//g ABF during priming.
.Administration of 50//g ABF did not alter response significantly (Figure 5.6). The priming 
dose of ABF influenced the proliferative responses of the PLN populations also, as shown 
in Figure 5.7. Increasing the amount of ABF at priming resulted in an increased 
depression of the non-specific proliferative response following Con A restimulation. This 
was in contrast to culturing with OVA where decreasing the dose of ABF increased the 
ability to depress the response. In another model of helminth product mediated 
immunosuppression (Hartmann et aL 1997), the ability to suppress proliferative responses 
has been attributed to a general dampening of antigen- or mitogen-specific responses. To 
investigate if this was the case with ABF, the PLN cells were cultured with both Con A 
and ABF simultaneously. In doing so the ability of the cells to proliferate actually 
increased, suggestive that the mechanism through which ABF suppresses proliferation,
As illustrated in Figure 5,8, ABF dose also affected the production of cytokines. Although 
no IL-4 or IL-5 could be detected in the culture supernatants, there were differences in
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1exposure to pABA-1 during OVA priming did not alter the ability of the population to
specific proliferative responses, when the dose of ABF used to immunise decreased so the 
suppression of OVA-specific IFN-y production increased. The effect of ABF dosage on
the production of antigen-specific antibody production is shown in Figure 5.9. Both OVA- 
specific IgGl and IgG2a levels are decreased if mice are exposed to ABF during OVA
■“ft;priming and the degree of suppression is directly proportional to the dose of ABF used.
ft'
5.2.3 Parasite-derived ABA-1 cannot influence the immune response  
against OVA and does not contribute towards the effects of ABF
While the data in section 5.2.1 indicated that the recombinant form of the Ascaris allergen, 
ABA-1, was unable to modulate the OVA-specific DTH response, it was unknown if this 
were also true of parasite-derived ABA-1 (pABA-1). This was an important issue as 
pABA-1 constitutes approximately half of the total protein in ABF and it was possible that 
pABA-1 may be post-transcriptionally modified or have a different tertiary structure from 
the recombinant protein which conferred immunomodulatory properties. To address this, 
ABF was applied to a gel filtration column that separated and allowed the collection of 
proteins according to molecular weight. This enabled the isolation of pABA-1 from the 
other protein components of ABF. BALB/c mice were immunised as before with lCX)//g
OVA alone or in addition to 250//g of the unfractionated, complete ABF, 100//g pABA-1 
or 250/fg fractionated ABF with the pABA-1 removed. All groups were challenged seven 
days later with 100//g HAO. The resulting DTH responses were assessed and seven days 
after challenge the mice were killed to analyse the cytokine, proliferative and antibody 
responses. The results, shown in Figure 5.10, indicate that exposure to pABA-1 (group 3), 
like rABA-1, during OVA sensitisation does little to interfere with the development of the 
DTH response. Furthermore, the ability of ABF to modulate the response was not 
dependent upon the presence of the allergen (group 4). The suppression seen with both 
fractionated ABF and complete ABF was statistically significant (p-value = 0.001).
.Examination of the PLN proliferative responses, as depicted by Figure 5.7, revealed that
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respond to culture with OVA in vitro (group 5). Interestingly, the mice primed with 
fractionated ABF from which the pABA-1 had been removed (group 6), showed 
depression of the OVA-specific response greater than that observed for the equivalent 
dosage of the unfiltered ABF (group 3). A further effect of immunisation with fABF was 
an ablation of the ABF-specific proliferative response, revealing that while pABA-1 did 
little in modulating die immune response, it contributed to ABF’s mitogenicity. Removal 
of pABA-1 did not impede fABF (group 6), in suppressing the production of OVA-specific
IFN-y or IgGl and IgG2a, Figures 5.8 and 5,9 respectively. However, decreases in ABF- 
specific IFN-y were noted, along with a drop in ABF- and rABA-1-specific IgGl titres.
5.2.4 The ability of ABF to suppress the DTH response cannot be 
assigned to a particular fraction of the A scaris  antigens  
By gel fractionating ABF, as discussed previously, its component molecules can be 
separated. The proteins segregate into three main groups as illustrated in the FPLC trace 
shown in Figure 5.11. The two peaks not containing pABA-1 were collected separately 
and were used to immunise BALB/c mice, in an attempt to identify the immunomodulatory 
components. Mice were immunised with OVA alone or in addition to 250//g 
unfractionated ABF (nABF), 100//g pABA-1, 250//g FPLC-purifled ABF peak 1 (peak 1) 
or 250//g FPLC-purified ABF peak 2 (peak 2) as before. Mice were challenged seven days 
later with 100//g HAO. It was found that by sensitising mice to OVA mixed with peak 1 
or peak 2 the development of the OVA-specific DTH response was significantly depressed 
(Figure 5.12, p-value < 0.005). Therefore, the immunomodulatory activity is present in 
both of the isolated ABF peaks.
Measurement of cytokine production by the PLN cell populations (Figure 5.13), revealed 
that non-specific production of IFN-y was greatly enhanced when mice were sensitised 
with OVA mixed with either nABF, pABA-1 or ABF peak 2. Immunisation with OVA 
and ABF peak 1 did not augment the production of non-specific IFN-y as well as the other
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Ascaris antigens, although the ABF-mediated suppression of OVA-specific IFN-y was
most pronounced with this fraction. No IL-4, IL-5 or IL-10 was detectable in any of the 
culture supernatants. These data are presented in Figure 5.13. The proliferative responses, 
shown in Figure 5.14, indicated that the presence of nABF, pABA-1 and ABF peak 2 at 
OVA sensitisation increased OVA-specific reactions above the levels observed in mice 
immunised with the antigen alone. Administration of ABF peak 1 had no effect upon the 
OVA-specific response. Identical effects were also seen with respect to rABA-1- and 
ABF-specific reactivity. Examination of antigen-specific antibody production indicated 
that the OVA-specific IgG2a response generated in these animals was depressed only 
when the mice were immunised with either normal ABF or ABF peak 2, (groups 2 and 5, 
Figure 5.15). Furthermore, levels of both ABF- and rABA-1-specific immunoglobulins 
were considerably reduced when mice were immunised with either peak 1 or 2 in 
comparison to the unfiltered ABF.
5.2.5 ABF-mediated immunosuppression is dependent on the timing of  
ABF exposure
While the data presented in the previous sections demonstrated that exposure to ABF 
during priming resulted in a dampening of the Thl-associated heterologous DTH response, 
it was unlcnown if the Ascaris antigens had similar effects upon an established response. 
Therefore groups of BALB/c mice were immunised with either 100//g OVA, alone or 
mixed with 250//g ABF as before. Those animals immunised with OVA alone were 
challenged one week later with 100//g HAO mixed with 250//g ABF and the OVA and 
ABF primed were exposed to HAO alone. As illustrated in Figure 5.16, ABF significantly 
depressed (p-value < 0.01) the DTH response if exposure occurred during antigen priming 
but it had no effects when administered at antigenic challenge. This demonstrates that 
there is a small window of opportunity during which ABF can mediate its effects.
The timing of exposure to ABF did not alter the ability of lymphocyte cultures to 
proliferate in response to Con A, (see Figure 5.17). While the OVA-specific proliferative
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response was depressed by priming in the presence of ABF, this effect was greater in 
animals that had been exposed to the antigens during antigen challenge. The response 
following restimulation with ABF was greatly reduced in the animals challenged in 
comparison to those primed with the ABF. This however reflects the point that priming
with ABF was adjuvant-assisted. Non-specific production of IFN-y, like proliferation, was
unaffected by the timing of ABF exposure; in both instances, as illustrated in Figure 5.18,
levels were enhanced following exposure to ABF. However, OVA-specific IFN-y was
only suppressed by the presence of ABF at priming, while exposure during challenge
enhanced production. Similai’ to ABF-specific proliferation, ABF-specific IFN-y was
greater in the primed animals but not in the challenged, again, this was probably due to 
adjuvant. IL-4 and IL-5 were undetectable in any cultures and no differences were
5^';observed regarding the production of IL-10 (data not shown). The antigen-specific 
antibody responses are shown in Figure 5.19. While levels of OVA-specific IgG2a f
■ftdecreased slightly as a result of sensitisation with ABF, they remained constant if exposure ; 
occurred at challenge only.
5.2.6 Effect of heat and chemical treatments on ABF and the 
implications this for immunosuppression
'inPrevious work on the E/S products of H. poly gyrus investigated the effects of extreme heat 
and pH on the stability of the immunomodulatory properties of the parasite proteins 
(Pritchard et al. 1994). It was decided to use this rationale for the basis to investigate the 
stability the proteins of ABF which had displayed these characteristics. Aliquots of ABF 
were either heated to 100°C for 30 minutes in a thermal cycler block or acid treated by 
lowering the pH to 2 by addition of 3.6M H2SO4, before neutralisation with 7M NaOH 
until pH7 was reached. BALB/c mice were immunised with 100//g of OVA alone or 
mixed with 250//g of untreated ABF, chemically treated ABF or heated ABF. Seven days 
later the mice were challenged with 100//g of HAO and one week post-challenge the 
animals were killed to analyse cytokine, proliferative and antibody responses.
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The data presented in Figure 5.20 shows that treating ABF with extremes of heat or pH has 
no major effect on the immunosuppressive effects with respect to the DTH response.
However, the ability of ABF to enhance the production of IFN-y following Con A
.i"
restimulation was maintained only in ABF that had been chemically treated. Sensitisation 
with the heated ABF resulted in a suppression of the cytokine’s production greater than in
the mice immunised with OVA alone (Figure 5.18). Levels of IFN-y secreted due to
culture with OVA were suppressed by all the forms of ABF used but was most pronounced 
when the heated ABF was used. Both heating and acid treatment of ABF lead to a
reduction in levels of ABF-specific IFN-y. Interestingly, this was not the case when ABA-
1-specific production was assessed, where priming witli untreated ABF resulted in the 
lowest levels of production.
As seen in Figure 5.17, proliferative responses following restimulation with either Con A 
or rABA-1 were identical in all the ABF sensitised mice as was the ability to suppress 
OVA-specific responsiveness. Acid treatment of ABF lead to a decrease in the ABF- 
specific response, but this decrease was most marked in the mice that received the heat 
treated ABF. Analysis of the levels of antigen-specific antibody in the sera, indicated that 
while the production of OVA-specific IgG2a was depressed following exposure to 
untreated ABF, priming with either heated ABF or acid treated ABF could reduce this 
response further. All groups immunised with the Ascaris antigens produced similar 
amounts of ABA-1 and ABF-specific IgGl, but ABA-1-specific IgG2a was greatest in the
'heated ABF immunised and ABF-specific IgG2a was enhanced in those administered 
untreated ABF (Figure 5.19).
ft:
were challenged with 100//g of HAO and the DTH response assessed. The mice were 
sacrificed one week post-challenge to measure the animals’ antibody, cytokine and 
proliferative responses.
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5.2 .7  E ffect o f  Ascaris  antigens on the O V A -specific  response  in IL-4
.deficient mice
ft...As described in the section 5.2.1, modulation of the OVA-specific DTH response by ABF
.was associated with alterations in cytokine production when compared to mice immunised 
with OVA alone. Products of other helminth species have been reported to promote the
Iproduction of Th2 cytokines in naive hosts (Mahanty et al. 1993; Steel and Nutman 1998), 
to determine whether ABF mediated its effect by a similar manner mice deficient for the f
Th2 associated cytokine IL-4 (IL-4 KO), were immunised with OVA alone or with ABF.
As a result of the increase in IL-10 production described in section 5.2.1 following 
exposure to ABF during OVA sensitisation, mice were treated with a neutralising 
monoclonal antibody against IL-10 prior to sensitisation to investigate if this affected 
ABF’s ability to suppress the DTH response. Groups of IL-4 KO and BIO.BR wild-type
(WT) controls were immunised as previously with 100//g OVA alone or mixed with 250//g
ftABF emulsified in a 50//1 volume with FCA. Seven days after sensitisation all groups
I
;
Immunisation of IL-4 KO mice with OVA alone resulted in the development of a strong 
DTH response similar to those observed in the wild-type controls. While addition of ABF 
to OVA at immunisation resulted in ablation of DTH in the WT animals this was not seen 
in the IL-4 deficients which only exhibited a slight diminution of the response. Treatment 
with neutralising IL-10 antibodies prior to immunisation with OVA and ABF had no 
discernible effect on the IL-4 KO mice and although a slight DTH response was seen in the 
control group this was still significantly lower in comparison to immunisation with OVA 
alone. These results are shown in Figure 5.21. Ï
The presence of ABF at immunisation lead to a 30% decrease in OVA-specific IFN-y 
production in the BIO.BR wild-types with a-IL-10 treatment ablating production totally.
In the IL-4 KOs no OVA-specific IFN-y could be detected following sensitisation with
ABF and in the KOs immunised with OVA alone the levels were considerably less than 
that detected in the wild-type animals (Figure 5.22), Interestingly, treatment of the IL-4
KO mice with a-IL-10 antibody resulted in a 90% increase in the production of OVA-
specific IFN-y. As found in the other experiments presented no IL-4 or IL-5 was 
measurable and IL-10 production was below the assay detection limit.
The proliferative responses by the PLN populations in these mice following restimulation 
in vitro with antigen are presented in Figure 5.23. The data shows that both wild-type and 
IL-4 KO animals responded well following culture with the Con A mitogen, except for the
WT mice treated with a-ILlO prior to sensitisation with OVA and ABF where the response
was decreased. When the populations were restimulated with OVA, an enhancement of 
the antigen-specific response in WT animals was seen as reported in previous sections 
when OVA was presented in association with ABF, This was not obsei'ved in the IL-4
KOs and treatment with a-IL-10 ablated this response in the WTs. No differences were
noted in the ability to respond due to culture with rABA-1, which was in contrast to ABF- 
induced proliferation. While WT mice responded strongly if exposed to ABF during
priming, IL-4 KOs did not. Furthermore, where injection with a-IL-10 abolished this 
response in the WTs it promoted ABF-specific proliferation in the IL-4 deficient mice.
Differences were also observed in antigen-specific immunoglobulin production (Figure 
5.24). OVA-specific IgGl levels were equivalent to those seen in the HAO controls for
the IL-4 KOs and addition of ABF or a-IL-10 did little to influence the production in the
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WTs. The reverse was recorded for OVA-IgG2a where the IL-4 KOs had increased 
relative responses in comparison to the WT controls. This pattern of reversed responses 
was also found for both the rABA-1- and ABF-specific antibodies. The most marked 
differences in production occurred in ABF-specific production. In the case of IgGl the 
WT mice responses were double that of the KOs and when IgG2a levels were assessed the 
difference was approximately three times greater in the KOs in comparison to the WTs.
As with OVA-specific production treatment of the mice with a-IL-10 had little influence 
on the rABA-1- or ABF-specific responses.
■„|i
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5.3 D iscussion
The data presented here demonstrate that exposure to ABF during priming for the OVA- 
specific DTH response results in a suppression of the heterologous response upon antigen 
challenge. This ability to suppress the response was found to occur in both BALB/c and
-BIO.S mice indicating that ABF could mediate its effects independently of the MHC,
'Ï;which had been reported for other parasite products with immunomodulatory activities 
(Fig. 5.1, (Robinson et al. 1994)). This was in contrast to other murine immune responses 
resulting from exposure to Ascaris products that have been shown to be tightly controlled 
by MHC genetics (Kennedy etal, 1986; Tomlinson etal. 1989).
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Analysis of the DTH reaction in mice primed for OVA in the presence of the ABA-1 |
revealed that the allergen, which contributes approximately 50% of the total protein in 
ABF (Kennedy and Qureshi 1986), did not afford the same immunosuppressive activity as 
described for ABF. This response occurred with both recombinant and native forms of the 
molecule, indicating that even if the parasite-derived form differs from the recombinant ::
protein in some way (i.e., protein folding or post-transcriptional modification), then this 
does not confer modulatory activities which the recombinant molecule does not possess.
-
Most significantly, these results suggested that the effects of ABF were not dependent 
upon the allergen. This point was confirmed by removing pABA-1 from ABF, where upon 
sensitisation of mice with the remaining ABF components still resulted in depressed DTH 
responses (Fig. 5.10). •èj
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There are a variety of candidates that may be the active component in ABF. One 
possibility is phosphorylcholine, against which antibodies are generated during Ascaris 
infection (Mitchell 1976), as phosphorylcholine has been shown to a major component of 
immunomodulatory products of the filarial nematodes Acanthocheilonema vitae and
'.i-;
Brugia malayi which are known to interfere with polyclonal activation of lymphocytes 
(Deehan et al. 1998; Harnett and Harnett 1993; Lai et al. 1990). Alternatively, 
carbohydrate residues may be important as has been shown with soluble egg antigens of
Schistosoma mansoni (Veliipillai et al. 1997), where removal of glycan units from the 
antigens lead to a decrease in the lL-10 production associated with early infection. A final 
possibility is that both lipid and glycan work in conjunction and two such molecules with 
biological activity have been described for Ascaris suum (Lochnit et al. 1998). Although 
the identity of the active component is unknown, heat and acid treatments of ABF indicate 
that with respect to immunomodulation at least, this component is very stable and resistant 
to harsh environmental conditions (Fig. 5.20).
Differences in in vitro cytokine production by PLN cells provided clues to the mechanisms 
of the immunosuppression. Mice primed with OVA and ABF produced IFN-y at
considerably lower levels than those given OVA alone or mixed with ABA-1 when 
stimulated with OVA, No lL-4 protein could be detected in any of the culture 
supernatants, this may be due to it being rapidly bound by cells either through cell surface 
or secreted soluble receptors. Culturing cells in the presence of blocking monoclonal 
antibodies against the IL-4 receptor would test this possibility. Interestingly, the decrease
in IFN-y did coincide with the production of OVA-specific IL-10 in cultures of the OVA
and ABF treated animals (Fig. 5.2). IL-10 was first reported as being a Th2 cell subset 
activity that inhibited Thl cell cytokine synthesis and its presence had also been shown to 
decrease contact hypersensitivity responses in mice (Ferguson et al. 1994; Fiorentino et a l 
1989). Therefore ABF may modulate the Thl-associated DTH response by inducing aTh2 
response through the production of IL-10, which decreased the associated pathology as a 
consequence.
Modifications of the proliferative response were not as marked as those observed for 
cytokine production (Fig. 5.3). Popliteal proliferative responses were similar in most 
groups following stimulation with a variety of antigens. Interestingly, die OVA-specific 
response was enhanced slightly as a result of sensitisation in the presence of ABF. 
Alterations in the ability of host cells to respond to antigen is frequently associated with
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Mice immunised with OVA and ABF produced significantly lower levels of OVA-specific 
IgG in compaiison to the OVA controls and OVA plus ABA-1 group (Fig. 5.4). The OVA
!
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parasite antigens (Deehan et al. 1998; Harnett and Harnett 1993; Hartmann et al. 1997; 
Robinson et al. 1994), and can occur through a general dampening of the antigen- or 
mitogen-specific immune response. However, mitogen-specific responses were unaffected 
following exposure to ABF and co-culturing with both Con A and ABF resulted in 
enhanced mitogenic activity indicating that an overall lowering in responsiveness was not 
responsible in this instance (Fig. 5.7).
"a
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.and ABF group also developed lower titres of rABA-1-specific IgG2a but were capable of
producing ABF-specific antibodies of both isotypes. This again highlighting that while 
ABF can modulate immunity to heterologous antigen this does not appear to be at any cost 
to the immune response generated against the parasite antigens themselves.
"ITaken together this data suggests that ABF can modulate the Thl-associated DTH
response possibly by inducing the development of a Th2-type response. Immunising IL-4 
deficient mice which had been treated with neutralising anti-IL-10 monoclonal antibodies 
allowed the assessment of the DTH response in mice that were lacking key Th2-promoting 
cytokines. Although IL-4 protein was not detectable in the cultures, the contribution of the 
cytokine could not be overlooked as not only is IL-4 crucial to Tii2 development and 
helminth products are strong promoters of Th2 cytokine production, but IL-4 has been 
demonstrated to synergise with IL-10 to inhibit cell-mediated immunity in vivo (Powrie et 
al. 1993b).
IL-4 deficient mice exposed to ABF at priming did generate DTH responses but which 
were slightly depressed in comparison to the OVA controls (Fig. 5.21). Pre-treatment with 
anti-IL-10 antibodies did not affect the footpad swelling measured in the KG mice and 
while it permitted some swelling in the wild-type controls, the response was still 
significantly lower than the OVA controls. Cytokine analysis revealed that wild-type and
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IL-4 in immunoglobulin production as had been expected. Therefore, this data indicates 
that while both IL-4 and IL-10 are influential to the immunomodulation seen with ABF the 
cytokines are responsible for different aspects of the response.
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IL-4 KO mice sensitised with OVA and ABF had either reduced or no production of IFN-y
following in vitro stimulation with OVA. Furthermore, OVA-specific IFN-y production
was increased in the anti-IL-10 antibody treated IL-4 deficients, suggestive of IL-10 
involvement, however, the wild-type mice that were treated in this way produced no OVA-
specific IFN-y at all. Antigen-specific IgGl and IgG2a levels were respectively lower and 
higher in the IL-4 KO mice relative to the wild-type controls reflecting the importance of
Finally further factors that influence the modulation of tlie DTH response by ABF are the
dose of parasite product used at sensitisation, as mentioned earlier, and whether exposure 
occurs during the primary or recall phase of the anti-OVA immune response. Suppression 
of the DTH response was found to occur in a dose dependent manner, with lower doses 
(e.g., 50/fg) failing to inhibit its development (Fig. 5.6). Similar effects of dosage were 
also noted with respect to the inhibition of antigen-specific cytokine and immunoglobulin 
production (Figs. 5.8 and 5.9). Following on from this, while mice that were exposed to 
ABF during primary or sensitisation phase of the DTH response suppressed the cell- 
mediated response, no effects were detectable when exposure occurred during the 
antigenic challenge or recall (Fig 5.16). This illustrates that while ABF is a potent 
immunomodulator it is quite specific in the ways in which it mediates its effects. iÏ
Ï
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Figure 5.1
Ascaris antigens suppress the development of the OVA-specific DTH response in mice. BALB/c and BIO.S 
mice were sensitised subcutaneously in the left hind footpad with antigens as indicated below emulsified in FCA, 
Controls left unimmunised. All groups were challenged 7 days later in the opposite foot. Thickness increase 
represents the mean difference between footpad size before and 24 hours post challenge within a test group.
* represents a p-value < 0.001 when compared to group 1 using a Student’s t-test.
Group Sensitisation Challenge
1 lOOpg OVA lOOpgHAO
2 lOOpg OVA + 500pg ABF lOOpgHAO
3 lOOpg OVA + lOOpg rABA-1 lOOpgHAO
4 lOOpg OVA + 500pg ABF 250pg soluble ABF
5 lOOpg OVA + lOOpg rABA-1 50pg soluble rABA-1
6 500pg ABF 250pg soluble ABF
7 lOOpg rABA-1 50pg soluble rABA-1
8 unimmunised lOOpg HAO
-H
I
0.6 BALB/c
0.4-
0.3-
0 .2 -
0.1
I 2 4
-H
1.25 BIO.S
0.75-
0.5
0.25
1 2 3 4 5 6
9 9
F i g u r e  5 .2
C y t o k i n e  p r o d u c t i o n  b y  p o p l i t e a l  l y m p h o c y t e s  o f  m i c e  e x p o s e d  t o  A sc a r is  a n t i g e n s  
d u r i n g  s e n s i t i s a t i o n  t o  O V A . IFNy and IL-10 protein levels were assessed in the culture supernatants 
of popliteal lymphocytes from BALB/c mice following in vitro restimulation for 72 hours. Mice were 
sensitised with antigens as detailed below emulsified in FCA in the left hind footpad. Controls were 
unimmunised. All groups were challenged 7 days opposite foot. Animals were sacrificed 7  days post- 
challenge and the popliteal lymphocytes within groups pooled. Cytokine production was measured using 
capture sandwich ELlSAs. 0 indicates detection lim it of assay.
Group Sensitisation Challenge
i D 100j4g OVA 100}4S HAO
100/^g OVA + SOOpig ABF IQOpig HAO
3 # lOO/ig OVA + 100/<g rABA-1 l(X)/<g HAO
4 | unimmunised lOOjAg HAO
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F igu re 5.3
A sc a r is  an tigens in fluence an tigen -sp ecific  p ro liferation  in  O V A  p rim ed  m ice. BALB/c 
mice were primed with antigens as indicated below emulsified in FCA and administered in the left hind 
footpad. Controls were unimmunised. A ll groups were challenged 7 days later in the opposite footpad. 
Animals were sacrificed one week later. The popliteal lymph nodes were pooled within groups and cultured 
in vitro with various stimuli as indicated for 72 hours. Cultures were pulsed with O.SpCi o f thymidine 
and incubated for a further 24 hours before harvesting. Each data point represents the mean uptake o f  
thymidine ± SEM for an experiment perfomied in triplicate.
Group Sensitisation Challenge
I lOOpg OVA lOOpgHAO
2 lOOpg OVA + 500|ig ABF lOOpg HAO
3 lOOpg OVA + lOOpg rABA-1 lOOpg HAO
4 unimmunised lOOpg HAO
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E x p o s u r e  to  p a r a s i t e  a n t i g e n s  d u r i n g  O V A  p r i m i n g  i n f l u e n c e s  t h e  p r o d u c t i o n  o f  
a n t i g e n - s p e c i f i c  im m u n o g l o b u l i n s .  BALB/c mice were sensitised with antigens detailed below  
emulsified in FCA via the left hind footpad. Controls were unimmunised. All groups were challenged 7  
days later. Mice were sacrificed one week later and sera collected. Antigen-specific antibodies were 
measured by ELISA. Data are expressed as the amount of antigen-specific antibody in a sample relative 
to the positive control in arbitraiy units. Each data point represents the mean ±  SEM for an experiment 
performed in triplicate.
 ^ represents a p-value < 0.007 and § approaching 0.007 when compared to group 1 (OVA-specific), 
group 6 (ABF-specific) or group 7  (rABA-1-specific) using a Student's r-test.
Group Sensitisation Challenge
1 lOOpig OVA 100/<g HAO
2 100/<g OVA + 500/<g ABF 100/(g HAO
3 lOO/^g OVA + 100/fg rABA-1 lOO^g HAO
4 100/^g OVA + SOOpig ABF 250pig soluble ABF
5 100/^g OVA + 100;^g rABA-1 50^g soluble rABA-1
6 SOO^g ABF 250^g soluble ABF
7 100/fg rABA-1 50/rg soluble rABA-1
8 unimmunised 100/<g HAO
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T otal serum  IgE con cen tration s in an im als exposed to A sc a r is  an tigens during O V A  
se n s itisa tio n . BALB/c mice were sensitised in the left hind footpad with antigens detailed below  
emulsified in FCA. Controls were left unimmunised. All groups were challenged 7 days later in the 
opposite foot. Animals were sacrificed one week post-challenge and sera collected for analysis by ELISA. 
Each data point represents the mean ± SEM for an experiment perfonned in triplicate.
* represents a p-value < 0.008 when compared to group 1 using a Student's t-test.
Group Sensitisation Challenge
1 lOOpg OVA lOOpgHAO
2 lOOpg O V A + SOOpgABF lOppg HAO •
3 lOOpg OVA + lOOpg rABA-1 lOOpg HAO
4 lOOpg OVA + SOOpg ABF 250pg soluble ABF
5 lOOpg OVA + lOOpg rABA-1 50pg soluble lA B A -1
6 500jLig ABF 250pg soluble ABF
7 lOOpg rABA-1 50pg soluble rABA-1
8 unimmunised lOOpgHAO
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Figure 5.6
ABF suppresses the O VA-specific DTH response in a dose dependent m anner. BALB/c mice were 
sensitised with antigens as detailed below emulsified in FCA via the left hind footpad. Controls were 
unimmunised. Challenge occurred one week later in the opposite foot. Thickness increase represents the mean 
difference between footpad size before and 24 hours post challenge within a test group.
represents a p-value < 0.001 using a Student’s t-test.
Group Sensitisation Challenge
1 lOOpg OVA lOOpg HAO
2 100pgOVA + 500pg ABF lOOpg HAO
3 lOOpg OVA + 250|ig ABF lOOpg HAO
4 lOOpg OVA + 50pg ABF lOOjig HAO
5 unimmunised lOOpg HAO
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Figure 5.7
The influence o f ABF dose and pABA-1 on proliferative responses of OVA-primed mice. BALB/c mice 
were sensitised with antigens as detailed below emulsified in FCA in the left hind footpad. Controls were 
unimmunised. Challenge occuned one week later in the opposite foot. Seven days post-challenge the animals 
were killed. Popliteal lymph node cells were pooled within groups and cultured in vitro with various stimuli as 
indicated for 72 hours. Cultures were pulsed with 0.5pCi o f  thymidine and incubated for a further 24 hours 
before harvesting. Each data pomt represents the mean uptake o f thymidine ± SEM.
Group Sensitisation Challenge
1 lOOpg OVA lOOpg HAO
2 lOOpg OVA + 500pg ABF lOOpg HAO
3 lOOpg OVA + 250pg ABF lOOpg HAO
4 lOOpgOVA+SOpgABF lOOpgHAO
5 lOOpg OVA + lOOpg pABA-1 lOOpg HAO
6 lOOpg OVA + 250pg fractionated ABF lOOpg HAO
7 unimmunised lOOpg HAO
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T h e  In fluence  o f  A B F  dose  a n d  pA B A -1 o n  IF N -y  p ro d u c tio n  in  O V A -p rim ed  m ice. BALB/c mice were 
sensitised with antigens detailed below emulsified in FCA in the left hind footpad. Controls were unimmunised. 
Challenge occurred one week later in the opposite foot. Seven days post-challenge the animals were killed. 
Popliteal lymph node cells were pooled within groups and restimulated in vitro with various stimuli as indicated 
for 72 hours. IFN-y protein levels were measured using capture sandwich ELIS As. 0 indicates detection limit of 
assay.
Group Sensitisation Challenge
I D lOOpig OVA lOO^g HAO
2 # lOOpig OVA + SOOpig ABF lOO^g HAO
3 | 100;Mg OVA + 250jWg ABF 100;<g HAO
4 | I00}ig OVA + 50;<gABF lOOjWg HAO
5 | 100;^g OVA + 100/<g pABA-1 100;<g HAO
lOOjMg OVA + 250/^g fractionated ABF lOOjig HAO
7 0 unimmunised 100/(g HAO
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Figure 5.9
T h e  in f lu en ce  o f  A B F  dose  a n d  pA B A -1  o n  an tig en -sp e c ific  a n tib o d y  p ro d u c tio n  in  O V A -p rim e d  m ice.
BALB/c mice were sensitised with antigens as detailed below emulsified in FCA in the left hind footpad. 
Controls were unimmunised. Challenge occurred one week later in the opposite foot. Mice were sacrificed 
seven days post-challenge and sera collected. Antigen-specific antibodies were measured by ELISA. Data are 
expressed as the amount o f antigen-specific antibody in a sample relative to the positive control in arbitrary units. 
Each data point represents tlie mean ± SEM for an experiment performed in triplicate.
* represents a p-value < 0.008 when compared to group 1 (OVA-specific), group 2 (ABF-specific) or group 5 
(rABA-1-specific) using a Student's Mest.
Group Sensitisation Challenge
1 lOOpg OVA lOOpgHAO
2 lOOpg OVA + 500pg ABF lOOpgHAO
3 lOOpg O V A +250pgA B F lOOpgHAO
4 lOOpg O V A + 50pgA B F lOOpg HAO
5 lOOpg OVA + lOOpg pABA-1 lOOpgHAO
6 lOOpg OVA + 250pg fractionated ABF lOOpg HAO
7 unimmunised lOOpg HAO
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F ig u re  5.10
T h e  su p p re ss io n  o f  th e  O V A -spec ific  D T H  re sp o n se  by  A B F  does n o t r e q u ire  th e  p re se n c e  o f  pA B A -1 .
BALB/c mice were sensitised in the left hind footpad with antigens detailed below emulsified in FCA. Controls 
were unimmunised. All groups were challenged one week later in the opposite foot. Thickness increase 
represents the mean difference between footpad size before and 24 hours post challenge within a test group.
represents a p-value < 0.001 when compared to group 1 using a Student's /-test.
Group Sensitisation Challenge
1 lOOpg OVA lOOpgHAO
2 100pgO V A +250pgA B F lOOpg FIAO
3 lOOpg OVA + lOOpg pABA-1 lOOpg HAO
4 lOOpg OVA + 250pg fractionated ABF lOOpg HAO
5 unimmunised lOOpgHAO
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S e p a ra tio n  o f  A B F  p ro te in s  b y  gel f ra c tio n a tio n .
In order to investigate the effects of parasite-derived ABA-1 and other body fluid proteins in isolation ABF was 
applied to a gel filtration column which separated the proteins according to molecular weight. A typical read-out 
trace from the procedure is illustrated. The proteins o f ABF were separated into three main groups as indicated. 
FPLC-purified peak 1, FPLC-purified peak 2 and parasite-derived ABA-1 are indicated on the trace by 1, 2 and 3 
respectively.
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Figure 5.12
Both FPLC-purified fractious o f ABF suppress the OVA-specific DTH response. BALB/c mice were 
immunised in the left hind footpad with antigens detailed below emulsified in FCA. Controls were unimmunised. 
All groups were challenged 7 days later in the opposite foot. Thickness increase represents the mean difference 
between footpad size before and 24 hours post challenge within a test group.
represents a p-value < 0.005 when compared to group 1 using a Student's Mest.
Group Sensitisation Challenge
1 lOOpg OVA lOOpgHAO
2 lOOpg OVA + 250pg ABF lOOpgHAO
3 lOOpg OVA + lOOpg pABA-1 lOOpgHAO
4 lOOpg OVA + 250pg ABF peak 1 lOOpgHAO
5 lOOpg OVA + 250pg ABF peak 2 lOOpgHAO
6 unimmunised lOOpgHAO
110
3 1
B
i
1250
1000
750
5 0 0 -
250
Medium Con A OVA rABA-1 
in vitro stimuli
F ig u re  5 .13
IFN -y p ro d u c tio n  in  th e  p o p lite a l ly m p h  n o d e  cell c u ltu re s  o f  m ice  exposed  to  F P L C -p u rif ie d  f r a c tio n s  o f  
A B F  d u r in g  O V A  p rim in g . BALB/c mice were immunised in the left hind footpad with antigens as detailed 
below emulsified in FCA. Controls were unimmunised. All groups were challenged 7 days later in the opposite 
foot. Animals were sacrificed one week later. The popliteal lymph nodes were pooled within groups and 
cultured in vitro with various stimuli as indicated for 72 hours. IFN-y production was measured in the culture 
supernatants using capture sandwich ELISAs. 0 indicates detection limit o f assay.
Group Sensitisation Challenge
I D lOOpig OVA 100/<g HAO
lOO/fg OVA4-250>«gABF lOOpg HAO
3 | lOOpg OVA + lOOpg pABA-1 lOOpg HAO
4 | lOOjMg OVA + 250pg ABF peak 1 lOOpg HAO
m I00j4g OVA + 250}ig ABF peak 2 lOOpg HAO
unimmunised lOO/fg HAO
I l l
Figure 5.14
Proliferation o f popliteal lymph node cells following immunisation with FPLC-purified fractions o f ABF  
during OVA priming. BALB/c mice were immunised in the left hind footpad with antigens detailed below  
emulsified in FCA. Controls were unimmunised. All groups were challenged 7 days later in the opposite foot. 
Animals were sacrificed one week later. The popliteal lymph nodes were pooled within groups and cultured in 
vitro with various stimuli as indicated for 72 hours. Cultures were pulsed with 0.5pCi o f thymidine and 
incubated for a further 24 hours before harvesting. Each data point represents the mean uptake o f thymidine ±  
SEM for an experiment performed in triplicate.
Group Sensitisation Challenge
1 lOOpg OVA lOOpgHAO
2 lOOpg OVA + 250pg ABF lOOpg HAO
3 lOOpg OVA + lOOpg pABA-1 lOOpg HAO
4 lOOpg OVA + 250pg ABF peak 1 lOOpg HAO
5 lOOpg OVA + 250pg ABF peak 2 lOOpg HAO
6 unimmunised lOOpg HAO
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Figure 5.15
Antigen-specific antibody production following exposure to FPLC-purified fractions of ABF during OVA  
priming. BALB/c mice were immunised in the left hind footpad with antigens detailed below emulsified in 
FCA. Controls were unimmunised. All groups were challenged 7 days later in the opposite foot Mice were 
sacrificed one week later and sera collected. Antigen-specific antibodies were measured by ELISA. Data are 
expressed as the amount o f antigen-specific antibody in a sample relative to the positive control in arbitrary units. 
Each data point represents the mean ± SEM.
* represents a p-value < 0.001 when compared to group 1 (OVA-specific) and group 2 (rABA-1- and ABF- 
specific) using a Student's t-test.
Group Sensitisation Challenge
1 lOOpg OVA lOOpgHAO
2 lOOpg OVA + 250pg ABF lOOpgHAO
3 lOOpg OVA + lOOpg pABA-1 lOOpg HAO
4 lOOpg OVA + 250pg ABF peak 1 lOOpgHAO
5 lOOpg OVA + 250|xg ABF peak 2 lOOpg HAO
6 unimmunised lOOpgHAO
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Figure 5.16
Suppression of the OVA-specific DTH response by ABF is dependent upon the timing of exposure to the 
parasite antigens, BALB/c mice were sensitised with antigens as detailed below emulsified in FCA via the left 
hind footpad. Controls were unimmunised. Challenge occurred 7 days post-sensitisation. Thickness increase 
represents the mean difference between footpad size before and 24 hours post challenge within a test group.
* represents a p-value <0.01 when compared to group 1 using a Student's /-test.
Group Sensitisation Challenge
1 lOOpg OVA lOOpg HAO
2 lOOpg OVA + 250pg ABF lOOpgHAO
3 lOOpg OVA lOOpg HAO + 250pg soluble ABF
4 unimmunised lOOpg HAO
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Figure 5.17
Tim ing of exposure to ABF and heat or chem ical treatments o f the antigens m odulates proliferation in  
popliteal lymph populations. BALB/c mice were primed with antigens detailed below emulsified in FCA in the 
left hind footpad. Controls were unimmunised (group 6). Groups were challenged 7 days post-sensitisation. 
Mice were killed one week later. Popliteal lymphocytes were pooled within groups and cultured in vitro with 
stimuli as indicated for 72 hours. Cultures were pulsed with 0.5pCi o f thymidine and incubated for a further 
24 hours before harvesting. Each data point represents the mean uptake o f  thymidine ± SEM for an experiment 
perfonned in triplicate. ND indicates experiment not done.
Group Sensitisation Challenge
1 lOOpg OVA lOOpgHAO
2 lOOpg OVA + 250pg ABF lOOpgHAO
3 lOOpg OVA + 250pg heated ABF lOOpg HAO
4 lOOpg OVA + 250pg acid treated ABF lOOpg HAO
5 lOOpg OVA lOOpg HAO + 250pg soluble ABF
6 unimmunised lOOpg HAO
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T im in g  o f  e x p o su re  to  A B F  a n d  h e a t o r  ch em ica l t r e a tm e n ts  o f  th e  a n tig e n s  a ffec ts  in vitro IFN -y  
p ro d u c tio n  b y  th e  p o p lite a l ly m p h  p o p u la tio n s . BALB/c mice were primed with antigens as detailed below 
emulsified in FCA in the left hind footpad. Controls were unimmunised. Challenge occurred 7 days post­
sensitisation. Animals were killed one week later and popliteal lymphocytes were pooled within groups for 
culture in vitro with stimuli as indicated for 72 hours. Culture supernatants were harvested and IFN-y protein 
levels were assessed by capture sandwich ELISA. 0 indicates detection limit o f assay.
Group Sensitisation Challenge
I D lOOjMg OVA lOO/ig HAO
2 # lOOpig OVA + 250/ig ABF lOOjWg HAO
3 | 100]4g OVA + 250j4g heated ABF lOO f^g HAO
4 0 lOOpig OVA + 250//g acid treated ABF 100/fg HAO
5 0 lOOpig OVA lOO/^g HAO + 250^g soluble ABF
unimmunised lOO/fg HAO
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Figure 5.19
Timing o f exposure to ABF and heat or chem ical treatm ents of the antigens influences production of  
antigen-specific immungiobuiins. BALB/c mice were primed with antigens detailed below emulsified in FCA 
in the left hind footpad. Controls were unimmunised (group 6). Challenge occurred 7 days post-sensitisation. 
Animals were killed one week later and sera collected. Antibody levels were assessed by ELISA. Data are 
expressed as the amount o f  antigen-specific antibody in a sample relative to the positive control in arbitrary units. 
Each data point represents the mean ± SEM for an experiment perfonned in triplicate.
* represents a p-value < 0.01 when compared to group 1 (OVA-specific) and group 2 (rABA-1- and ABF- 
specific) using a Student’s Atest.
Group Sensitisation Challenge
1 lOOpg OVA lOOpg HAO
2 lOOpg OVA + 250pg ABF lOOpg HAO
3 lOOpg OVA + 250pg heated ABF lOOpg HAO
4 lOOpg OVA + 250pg acid treated ABF IGOpg HAO
5 lOOpg OVA lOOpg HAO + 250pg soluble ABF
6 unimmunised lOOpgHAO
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Figure 5.20
The ability to suppress the OVA-specific DTH response by ABF is unaltered by heating or chem ically  
treatment prior to use. BALB/c mice were sensitised with antigens detailed below emulsified in FCA in the left 
hind footpad. Controls were unimmunised. All groups were challenged one week later in the opposite foot. 
Thickness increase represents the mean difference between footpad size before and 24 hours post challenge 
within a test group.
* represents a p-value < 0.01 and § approaching significance when compared to group 1 using a Student's r-test.
Group Sensitisation Challenge
1 lOOpg OVA lOOpg HAO
2 lOOpg OVA + 250pg ABF lOOpgHAO
3 lOOpg OVA + 250pg heated ABF lOOpg HAO
4 lOOpg OVA + 250pg acid treated ABF lOOpg HAO
5 unimmunised lOOpg HAO
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Figure 5.21
The influence of ABF on the development of the OVA-specific DTH response in IL-4 deficient and anti-IL- 
10 monoclonal antibody treated mice. BIO.BR controls and IL-4 deficient mice were sensitised with antigens 
detailed below emulsified in FCA in the left hind footpad. Controls were unimmunised. In addition groups were 
treated with neutralising rat-anti-mouse IL-IO monoclonal antibodies or rat isotype control antibodies two hours 
pre-sensitisation. All groups were challenged one week later in the opposite foot. Thickness increase represents 
the mean difference between footpad size before and 24 hours post challenge within a test group.
* represents a p-value ^ 0.001 when compared to group 1 using a Student's f-test.
Group Sensitisation Challenge Antibody treatment
1 lOOpg OVA lOOpg HAO 200pg isotype control
2 lOOpg OVA-t-250pg ABF lOOpg HAO 200pg isotype control
3 lOOpg OVA + 250pg ABF lOOjxg HAO 200pg anti-IL-IO
4 250pg ABF lOOpgHAO -
5 unimmunised lOOpgHAO -
0.5 BIO.BR
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Figure 5.22
T h e  in fluence  o f  ex p o su re  to  A B F  d u r in g  O V A  sen s itisa tio n  on  IFN -y  p ro d u c tio n  in  IL -4  d e fîc ien t a n d  
an ti-IL -IO  m o n o c lo n a l a n tib o d y  tr e a te d  m ice. BIO.BR controls and IL-4 deficient mice were sensitised with 
antigens detailed below emulsified in FCA in the left hind footpad. Controls were unimmunised. In addition, 
animals were immunised with neutralising rat-anti-mouse IL-10 monoclonal antibodies or rat isotype control 
antibodies two hours pre-sensitisation. All groups were challenged one week later in the opposite foot. Seven 
days post-challenge the mice were killed and the popliteal lymph node cells from mice within groups pooled and 
cultured for 72 hours in vitro with various stimuli as indicated. Culture supernatants were measured for IFN-y 
production by capture sandwich ELISA.
Group Sensitisation Challenge Antibody treatment
I D lOOpts OVA lQ0f4g HAO 200jwg isotype control
2 | 100/<g OVA + 250/^g ABF 100/<g HAO 200/<g isotype control
3 | 100/<g OVA + 250f4g ABF 100/fg HAO 200/fg anti-lL-10
4 l unimmunised lOO/fg HAO -
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Figure 5.23
The influence o f exposure to ABF during OVA sensitisation on proliferative responses in IL-4 deficient 
and anti-IL-IO monoclonal antibody treated mice. BIO.BR controls and IL-4 deficient mice were sensitised 
with antigens as detailed below emulsified in FCA in the left hind footpad. Controls were unimmunised. In 
addition, animals were immunised with neutralising rat-anti-mouse IL-10 monoclonal antibodies or rat isotype 
control antibodies two hours prior to sensitisation. All groups were challenged one week later in the opposite 
foot. Seven days post-challenge the mice were killed and the popliteal lymph node cells from mice within groups 
pooled and cultured for 72 hours in vitro with various stimuli as indicated. Cultures were pulsed with 0.5pCi o f  
thymidine and incubated for a further 24 hours before harvesting. Each data point represents the mean uptake 
o f thymidine ± SEM for an experiment perfonned in triplicate.
Group Strain Sensitisation Challenge Antibody treatment
1 BIO.BR lOOpg OVA lOOpg HAO 200pg isotype control
2 IL-4 KO lOOpg OVA lOOpg HAO 200pg isotype control
3 BIO.BR lOOpg OVA + 250pg ABF lOOpg HAO 200pg isotype control
4 IL-4 KO lOOfig OVA + 250pg ABF lOOpg HAO 200pg isotype control
5 BIO.BR lOOjig OVA + 250fig ABF lOOpg HAO 200pg anti-IL-IO
6 IL-4 KO lOOpg OVA + 250pg ABF lOOpgHAO 200pg anti-IL-IO
7 BIO.BR unimmunised lOOpgHAO -
8 IL-4 KO unimmunised lOOpgHAO -
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Figure 5.24
The influence of exposure to ABF during OVA sensitisation on antigen-specific antibody production in IL- 
4 deficient and anti-IL-IO monoclonal antibody treated mice. BIO.BR controls and IL-4 deficient mice were 
sensitised with antigens as detailed below emulsified in FCA in the left hind footpad. Controls were 
unimmunised. In addition, animals were immunised with neutralising rat-anti-mouse IL-10 monoclonal 
antibodies or rat isotype control antibodies two hours pre-sensitisation. All groups were challenged one week 
later in the opposite foot. Seven days post-challenge the mice were killed and the sera collected. Antigen- 
specific antibodies were measured by ELISA. Data are expressed as the amount o f  antigen-specific antibody in a 
sample relative to the positive control in arbitrary units. Each data point represents the mean ± SEM for an 
experiment perfonned in triplicate.
* and # represents a p-value < 0.005 when compared to groups 1 and 2 (OVA-specific) and groups 3 and 4 (ABF- 
and rABA-1-specific) respectively using a Student's r-test. § represents a p-value < 0.005 when control mice are 
compared to IL-4 deficient mice which have undergone identical treatment.
Group Strain Sensitisation Challenge Antibody treatment
1 BIO.BR lOOpgGVA lOOpgHAG 200|Lig isotype control
2 IL-4 KG lOOfig GVA lOOpg HAG 200pg isotype control
3 BIO.BR lOOjug GVA + 250pg ABF lOOpg HAG 200pg isotype control
4 IL-4 KG lOOpg GVA + 250pg ABF iOOpg HAO 200pg isotype control
5 BIO.BR lOOpg GVA + 250|xg ABF lOOpg HAG 200pg anti-IL-IO
6 IL-4 KG lOOpg GVA + 250pg ABF lOOpg HAG 200pg anti-IL-IO
7 b io .b r unimmunised lOOpg HAO -
8 IL-4 KG unimmunised lOOpg HAG -
OVAIgGl
3 -
2 ~
1 2 3 4 5 6 7 8
rABA-1 IgGl
S
-HG
iCk
T  ^
1 2 3 4 5 6 7 8
ABF IgGl
3 -
2 -
1 2 3 4 5 6 7 8
OVAIgG2a
2 -
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rABA-1 IgG2a
2 “
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ABF IgG2a
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CHAPTER 6
DISCUSSION AND CONCLUSIONS
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D iscu ssion  and conclusions
The aims of the experiments presented in this thesis were (1), to elucidate the nature of the 
immune response generated as a consequence of A. suum infection, (2), to investigate the
effects of immunisation with Ascaris products on the development of such responses and 
(3) to establish whether Ascaris pro 
of a heterologous immune response.
ducts had immunomodulatory properties in the context
The data presented in chapter 3 described the effects of Ascaris infection in the murine 
host. The natural host for A. suum is the pig and the adult form of the paiasite is reported 
on average to be 200 -  300mm in length (Crompton 1989). Therefore, due to anatomical 
constraints it is not possible for infections of mice to reach full patency, although the 
larvae can survive to the L3 to L4 moult in the lungs. Thus, infections of mice with 
Ascaris can only provide data on the immune response generated as a consequence of 
infection and not the development of protective immunity. Nevertheless the immune 
response of mice to Ascaris can provide information on the antigens relevant to human 
infections (Kennedy et at. 1986).
and a decrease in the Thl-associated IFN-y and these differences in cytokine production 
became more pronounced as the number of infections increased. This was similar to
I
■;s:;
Infection with Ascaris was found to promote the generation of a Th2-type immune 
response, characterised by an increase in production of the Th2-associated cytokine IL-4
findings that had been reported for other helminth species (Finkelman et al. 1991). It was 
noted that the initial increase in IL-4 was not as striking as the approximately 50%
reduction in IFN-y, thus highlighting the dominance that IL-4 has in inducing Th2
responses over the Thl-polaiising cytokine and that once the threshold for IL-4 has been 
reached there is a progressive increase in its production (Abbas et al. 1996; Hsieh et al. 
1993). The production of antigen-specific immunoglobulins reflected the differences that 
had been observed with cytokine secretion where levels of Thl-associated IgG2a
■I
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result of infection while the levels in B10.S(9R) (H-2'^ )^ and C57BL/10 (H-2^) secreted
also known that expression of the I-E^ molecule, which occurs in BIO.S but not in
significantly decreased after only one infection while a significant increase in Th2- 
associated IgGl developed after two or more. Both total and antigen-specific (data not 
shown for the latter) serum IgE production increased in direct proportion to the number of 
infections, but the contribution that the antigen-specific IgE made to the total amount of 
IgE produced was not estimated. This is a point which should be addressed in future 
studies as protective immunity in humans has been shown to be associated with an increase 
in antigen-specific IgE and a decrease in polyclonal IgE production (Kennedy et al. 1990; 
McSharry et al. 1999).
The selective expansion of CD4^ T cell subsets and the development of a protective or 
susceptible response phenotype has been described in a variety of infectious diseases such 
as leismaniasis, leprosy and trichuriasis (Abbas et al. 1996; Else and Grencis 1991b; 
Locksley and Scott. 1991). The influence of host genetics has also been demonstrated in 
the antigen recognition profiles generated following immunisation with Ascam-derived 
products (Kennedy et al. 1990; Tomlinson et al. 1989). Therefore, the effects of host
genetics on the immune response generated following Ascaris infection was investigated. 
It was found that mice of the BIO.S (H-2®) strain produced large amounts of IL-4 as a
little or none respectively, while IFN-y was undetectable in both BIO.S and C57BL/10 and
greatly reduced (94%) in the B10.S(9R). Analysis of antigen-specific antibody production 
revealed that all the strains had significantly more IgGl following infection and that IgG2a 
was low in all groups apart from the uninfected B10.S(9R) wliich had secreted the greatest
amount of IFN-y. This variability in immune responsiveness was surprising in light of the
fact that all the animals were on a BIO background. However, a possible explanation for
:this phenomenon may lie in the MHC loci of the mice. Antibody responses against the
products of Ascaris are known to be restricted by the I-A element of the MHC particularly 
I-A\ which all the strains used expressed (Kennedy et al. 1991; Kennedy et al. 1990). It is
125
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B10.S(9R) and C57BL/10, is associated with susceptibility to infection (Wassom et al.
1987). Therefore, if expression of I-E*^  were to make B10.S(9R) and C57BL/10 mice more 
susceptible to infection one would expect these mice to have diminished IL-4 secretion and
enhanced IFN-y, as was observed. Alternatively, these differences could arise due to
polymorphisms in the structural genes and promoters of MHC-encoded cytokines such as
tumour necrosis factors a  and p and IL L It should however be noted that this is not the
only possible explanation for the influence of host genetics on immune responsiveness. A 
study using a TcR transgenic system analysed the cellular components in which genetic 
susceptibility to disease may arise. This work revealed that APCs play little or no part in 
deteimining Thl/Th2 balance and that this ability lies within the T cells themselves (Hsieh 
etal. 1995).
The features of helminth infection that bias the immune response to a Th2 phenotype are 
unknown, but the associated production of IgE and hypersensitivity responses has focussed 
attention on parasite products (Ogilvie and Savigny 1982). Challenge of -primed
mice with ABF emulsified in FCA (Chapter 3) abolished the production of IL-4 in favour
of IFN-y and depressed total IgE levels. In contrast, this enhanced antigen-specific
immunoglobulin production further. It was of considerable interest to examine whether
.these effects could also be observed by using the major allergen of Ascaris, ABA-1, which 
is thought to be equivalent to the Allergen A molecule first described in the early 1970s 
(Ambler et al. 1973a; Ambler et al. 1973b; Christie et al. 1990; Kennedy et al. 1986). 
Although exposure to ABA-1 did have some influence on the immune response generated 
by infection, the effects were not as marked as those observed with ABF. Following on 
from this, the ability of rABA-1 to directly stimulate Th2 responses in vivo was examined 
by immunising naive animals with the allergen mixed with various adjuvants. The data 
obtained from this experiment revealed that rABA-1 was not a significant Th2-promoting 
parasite product on its own. It is not known whether the ability to stimulate Th2-type
2
responses directly is a characteristic of ABF and this is an issue that should be addressed in
future studies.
Priming mice with OVA alone or in the presence of the Ascaris products revealed that 
while both rABA-1 and pABA-1 had no influence on the development of the Thl-type 
DTH response against OVA, exposure to ABF resulted in a total inhibition of the response
An extension of the work investigating whether the products of Ascaris can promote Th2
responses would be to assess their contribution to the generation of allergic responses in
the host respiratory tract during infection. An immediate hypersensitivity response, similar
to asthma, (Loeffler’s syndrome) occurs frequently in individuals intermittently infected
with Ascaris and is associated with the migration of larval stages of the parasite through 
'the lung tissues (Ogilvie and Savigny 1982). It is not known whether a physical property 
of infection, e.g., lung blockade by the larvae, is the principal cause of the allergic 
response, or if there is an additional requirement for parasite products. The development 
of pathological immune responses in the lungs of mice can be studied, for example, by 
injecting antigen-coated sephadex beads via the tail vein, from where there is a rapid 
embolisation to the microvasculature of the lungs. This approach has been used 
successfully in other models of lung disease (Chensue et al, 1989; Chensue et al. 1995).
As immunisation with the products of Ascaris did not appear to induce Th2-type responses
it was decided to assess the effects of the products on the development of a heterologous
immune response. Helminth infections have been shown to break T cell tolerance which
may trigger autoimmune disease, interfere with the induction of oral tolerance, increase
susceptibility to secondary infections and modulate the immune response to non-parasite
antigens and other pathogens (Actor et al. 1993; Curry et al. 1995; Hermanek et al. 1994;
.Rocken et al. 1992a; S hi et al. 1998). Similar effects have also been reported following 
exposure to parasite antigens and E/S products (Allen and MacDonald 1998; Deehan et al. 
1997; Harnett and Harnett 1993; Ottensen etal. 1977).
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and was not influenced by the host MHC haplotype. Analysis of cytokine production in 
the draining lymph nodes revealed that immunisation with ABF resulted in a marked
decrease in OVA-specific IFN-y and was accompanied by an increase in both mitogen and
OVA-stimulated IL-10. Although no IL-4 was detected in the cultures, the cytokine was 
thought to contribute towards ABF’s modulatory activities because mice deficient for the 
cytokine developed DTH responses. Additionally, the effects of ABF were found to be 
dependent on dose; immunisation with less than 250/^g had no effect, the active factor was 
resistant to heat and acid treatments, and was only influential if administered during a 
primary immune response. Perhaps the most interesting discovery was that 
immunomodulation by ABF did not require the presence of ABA-L In an attempt to 
identify the immunomodulatory component(s), ABF was applied to a gel filtration column 
that separated proteins according to molecular weight. This produced two ABA-1-free 
fractions of ABF which both suppressed the development of a DTH response, unlike ABA- 
1 on its own.
A natural continuation of this project would be to further investigate and hopefully identify 
the component(s) responsible for the immunomodulatory activities of ABF. Possible 
candidates include two recently described glycolipid molecules that have been reported to 
have biological activity (Lochnit et al. 1998). There are a number of ways in which this 
could be carried out. Proteinase treatment, modifications of carbohydrate groups by 
periodate oxidation or deglycosylation of ABF are examples of approaches that could 
identify the nature of the component involved. A second approach could be to investigate 
the effects that High Pressure Liquid Chromatography (HPLC) purified peaks of ABF had 
on addition to APC assays, which is a system where the proliferation of primed T cells 
cultured with APCs of the same haplotype is assessed upon addition of soluble proteins. 
Alternatively, 2-D gel analysis proteomics could be used to investigate the role of 
polypeptide based components. Electrophoresis of ABF in a 2-D gel system would give 
fine separation of the component molecules that could then be Western blotted onto nitro-
. a . , . .
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which stimulate the proliferation of primed cells, mass spectrometry can be used to
129
identify the activity, this approach, however, relying upon there being pre-existing 
appropriate knowledge in data bases. The ability to isolate such a component and study its :;S"
effects both in vitro and in vivo could possibly have long-term implications for vaccine 
design and the treatment of allergic disease.
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